| ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
| TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
| | | |
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |
| | | |
| (Address of principal executive offices) | (Zip Code) |
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| | | |
| Large accelerated filer ☐ | Accelerated filer ☐ | | Smaller reporting company | Emerging growth company |
|
Page
|
||
| 1 | ||
|
PART I
|
2 | |
|
Item 1.
|
3 | |
| 3 | ||
| 4 | ||
| 5 | ||
| 6 | ||
| 6 | ||
| 7 | ||
| 8 | ||
| 8 | ||
| 9 | ||
| 9 | ||
| 10 | ||
| 10 | ||
| 11 | ||
| 11 | ||
| 11 | ||
| 12 | ||
|
Item 1A.
|
12
|
|
|
Item 1B.
|
12 | |
|
Item 1C.
|
12 | |
|
Item 2.
|
13 | |
|
Item 3.
|
13 | |
|
Item 4.
|
14 | |
|
PART II
|
||
|
Item 5.
|
14 | |
|
Item 6.
|
14 | |
|
Item 7.
|
14
|
|
|
Item 7A.
|
24 | |
|
Item 8.
|
25 | |
|
Item 9.
|
75 | |
|
Item 9A.
|
75 | |
|
Item 9B.
|
76 | |
|
Item 9C.
|
76 | |
|
PART III
|
||
|
Item 10.
|
77 | |
|
Item 11.
|
81 | |
|
Item 12.
|
82 |
|
|
Item 13.
|
83 | |
|
Item 14.
|
84 | |
|
PART IV
|
||
|
Item 15.
|
85 | |
|
Item 16.
|
86 | |
| 87 | ||
| 88 | ||
| 91 | ||
| 93 | ||
| 94 |
| Item 1. |
Business
|
|
Year Ended December 31,
|
||||||||
|
2025
|
2024
|
|||||||
|
(In thousands)
|
||||||||
|
Automobile liability
|
$
|
49,640
|
$
|
39,788
|
||||
|
Automobile physical damage
|
16,515
|
13,464
|
||||||
|
General liability
|
6,121
|
5,990
|
||||||
|
Surety
|
5,178
|
5,809
|
||||||
|
Inland marine
|
7,050
|
2,638
|
||||||
|
Total
|
$
|
84,504
|
$
|
67,689
|
||||
|
Year Ended December 31,
|
||||||||
|
2025
|
2024
|
|||||||
|
(Restated)
|
||||||||
|
(In thousands)
|
||||||||
|
Group life
|
$
|
12,559
|
$
|
14,270
|
||||
|
Individual life
|
5,600
|
5,922
|
||||||
|
Total life
|
18,159
|
20,192
|
||||||
|
Medicare Supplement
|
75,360
|
71,766
|
||||||
|
Group accident and health
|
9,178
|
11,469
|
||||||
|
Other individual health
|
8,941
|
7,472
|
||||||
|
Total health
|
93,479
|
90,707
|
||||||
|
Total
|
$
|
111,638
|
$
|
110,899
|
||||
|
1.
|
Capital and surplus fell from the beginning to the end of 2025, mainly due to non-admitted agent balance advances. ACLAC’s increased advances to agents reflect industry practices as it grows new business.
|
|
2.
|
Gross change in capital and surplus: see above explanation.
|
|
3.
|
Net income for 2025 was negative, driven by federal taxes. Operational gains were offset by these taxes, resulting in a net loss.
|
|
4.
|
ACLAC writes and cedes only Medicare Supplement insurance, so investment income adequacy always yields no result.
|
|
5.
|
Non-admitted assets spiked in 2025 due to agent balances; see item 1 for details.
|
|
6.
|
Surplus Relief ratio triggered because the ratio of commission and expense allowances to capital exceeds 100%. ACLAC writes only Medicare Supplement insurance and cedes 100% of its written business to its
parent, therefore the change in product mix ratio will always produce no result.
|
|
December 31,
|
||||||||||||||||
|
2025
|
2024
|
|||||||||||||||
|
Amount
|
Percent
|
Amount
|
Percent
|
|||||||||||||
|
|
(In thousands)
|
|||||||||||||||
|
Fixed maturity securities:
|
||||||||||||||||
|
U.S. Treasury securities and obligations of U.S. Government agencies and authorities
|
$
|
24,067
|
9.1
|
%
|
$
|
22,251
|
9.7
|
%
|
||||||||
|
Loan backed and structured securities
|
29,033
|
10.9
|
22,290
|
9.7
|
||||||||||||
|
States, municipalities and political subdivisions
|
7,335
|
2.8
|
7,623
|
3.3
|
||||||||||||
|
All other corporate bonds
|
183,472
|
69.1
|
160,261
|
69.6
|
||||||||||||
|
Redeemable preferred stock
|
204
|
0.1
|
187
|
0.1
|
||||||||||||
|
Total fixed maturity securities(1)
|
244,111
|
92.0
|
212,612
|
92.4
|
||||||||||||
|
Equity securities(2)
|
12,395
|
4.7
|
7,900
|
3.4
|
||||||||||||
|
Other invested assets(3)
|
6,037
|
2.2
|
6,616
|
3.0
|
||||||||||||
|
Policy loans(4)
|
1,683
|
0.6
|
1,722
|
0.7
|
||||||||||||
|
Real estate
|
38
|
0.0
|
38
|
0.0
|
||||||||||||
|
Investments in unconsolidated trusts
|
1,238
|
0.5
|
1,238
|
0.5
|
||||||||||||
|
Total investments
|
$
|
265,502
|
100.0
|
%
|
$
|
230,126
|
100.0
|
%
|
||||||||
|
(1)
|
Fixed maturity securities are carried on the balance sheet at estimated fair value. Certain fixed maturity securities do not have publicly quoted prices, and are carried at estimated fair value as determined
by management. Total amortized cost of fixed maturity securities was $260.2 million as of December 31, 2025 and $236.3 million as of December 31, 2024.
|
|
(2)
|
Equity securities are carried on the balance sheet at estimated fair value. Total cost of equity securities was $4.9 million as of December 31, 2025 and 2024.
|
|
(3)
|
Other invested assets are accounted for using the equity method. Total cost of other invested assets was $7.9 million as of December 31, 2025 and 2024.
|
|
(4)
|
Policy loans are valued at unpaid principal balances.
|
|
Year Ended December 31,
|
||||||||
|
2025
|
2024
|
|||||||
|
(Dollars in thousands)
|
||||||||
|
Average investments(1)
|
$
|
297,722
|
$
|
280,420
|
||||
|
Net investment income
|
10,266
|
9,791
|
||||||
|
Average yield on investments
|
3.5
|
%
|
3.5
|
%
|
||||
|
Realized investment gains (losses), net
|
(471
|
)
|
1,210
|
|||||
|
(1)
|
Calculated as the average of cash and investment balances (at amortized cost) at the beginning of the year and at the end of each of the succeeding four quarters.
|
|
Name
|
Age
|
Positions with the Company
|
Director or Officer Since
|
|||
|
Hilton H. Howell, Jr.
|
64
|
Chairman of the Board, President, CEO
|
1992
|
| Item 1A. |
Risk Factors
|
| Item 1B. |
Unresolved Staff Comments
|
| Item 1C. |
Cybersecurity
|
| Item 2. |
Properties
|
| Item 3. |
Legal Proceedings
|
| Item 4. |
Mine Safety Disclosures
|
| Item 5. |
Market for Registrant’s Common Equity, Related Shareholder Matters and Issuer Purchases of Equity Securities
|
|
Period
|
Total
Number
of Shares
Purchased
|
Average
Price Paid
per Share
|
Total
Number of Shares
Purchased as Part of
Publicly Announced
Plans or Programs
|
Maximum
Number of Shares
that May Yet be
Purchased Under the
Plans or Programs
|
||||||||||||
|
October 1 – October 31, 2025
|
-
|
$
|
-
|
-
|
325,129
|
|||||||||||
|
November 1 – November 30, 2025
|
-
|
-
|
-
|
325,129
|
||||||||||||
|
December 1 – December 31, 2025
|
-
|
-
|
-
|
325,129
|
||||||||||||
|
Total
|
-
|
$
|
-
|
-
|
||||||||||||
| Item 6. |
Reserved
|
| Item 7. |
Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
|
Year Ended December 31,
|
||||||||
|
2025
|
2024
|
|||||||
|
(Restated)
|
||||||||
|
(In thousands)
|
||||||||
|
Revenue
|
||||||||
|
Property and Casualty:
|
||||||||
|
American Southern
|
$
|
88,478
|
$
|
72,220
|
||||
|
Life and Health:
|
||||||||
|
Bankers Fidelity
|
121,701
|
115,953
|
||||||
|
Corporate and Other
|
261
|
(91
|
)
|
|||||
|
Total revenue
|
$
|
210,440
|
$
|
188,082
|
||||
|
Income (loss) before income taxes
|
||||||||
|
Property and Casualty:
|
||||||||
|
American Southern
|
$
|
4,718
|
$
|
888
|
||||
|
Life and Health:
|
||||||||
|
Bankers Fidelity
|
12,876
|
7,795
|
||||||
|
Corporate and Other
|
(9,873
|
)
|
(10,308
|
)
|
||||
|
Income (loss) before income taxes
|
$
|
7,721
|
$
|
(1,625
|
)
|
|||
|
Net income (loss)
|
$
|
6,017
|
$
|
(1,393
|
)
|
|||
|
Year Ended December 31,
|
||||||||
|
2025
|
2024
|
|||||||
|
(Restated)
|
||||||||
|
(In thousands)
|
||||||||
|
Reconciliation of Non-GAAP Financial Measure
|
||||||||
|
Net income (loss)
|
$
|
6,017
|
$
|
(1,393
|
)
|
|||
|
Income tax expense (benefit)
|
1,704
|
(232
|
)
|
|||||
|
Realized investment (gains) losses, net
|
471
|
(1,210
|
)
|
|||||
|
Unrealized (gains) losses on equity securities, net
|
(4,491
|
)
|
1,516
|
|||||
|
Non-GAAP operating income (loss)
|
$
|
3,701
|
$
|
(1,319
|
)
|
|||
|
Year Ended December 31,
|
||||||||
|
2025
|
2024
|
|||||||
|
(Dollars in thousands)
|
||||||||
|
Gross written premiums
|
$
|
96,599
|
$
|
73,671
|
||||
|
Ceded premiums
|
(6,165
|
)
|
(5,979
|
)
|
||||
|
Net written premiums
|
$
|
90,434
|
$
|
67,692
|
||||
|
Net earned premiums
|
$
|
84,504
|
$
|
67,689
|
||||
|
Insurance benefits and losses incurred
|
65,254
|
55,767
|
||||||
|
Commissions and underwriting expenses
|
18,506
|
15,565
|
||||||
|
Underwriting income (loss)
|
$
|
744
|
$
|
(3,643
|
)
|
|||
|
Loss ratio
|
77.2
|
%
|
82.4
|
%
|
||||
|
Expense ratio
|
21.9
|
%
|
23.0
|
%
|
||||
|
Combined ratio
|
99.1
|
%
|
105.4
|
%
|
||||
|
Year Ended December 31,
|
||||||||
|
2025
|
2024
|
|||||||
|
(In thousands)
|
||||||||
|
Automobile liability
|
$
|
49,640
|
$
|
39,788
|
||||
|
Automobile physical damage
|
16,515
|
13,464
|
||||||
|
General liability
|
6,121
|
5,990
|
||||||
|
Surety
|
5,178
|
5,809
|
||||||
|
Inland marine
|
7,050
|
2,638
|
||||||
|
Total
|
$
|
84,504
|
$
|
67,689
|
||||
|
Year Ended December 31,
|
||||||||
|
2025
|
2024
|
|||||||
|
(Restated)
|
||||||||
|
(In thousands)
|
||||||||
|
Gross earned premiums
|
$
|
179,872
|
$
|
164,135
|
||||
|
Ceded premiums
|
(68,234
|
)
|
(53,236
|
)
|
||||
|
Net earned premiums
|
111,638
|
110,899
|
||||||
|
Insurance benefits and losses incurred
|
72,287
|
68,311
|
||||||
|
Future policy benefit remeasurement gain
|
(4,866
|
)
|
(2,334
|
)
|
||||
|
Commissions and underwriting expenses
|
41,404
|
42,181
|
||||||
|
Total expenses
|
108,825
|
108,158
|
||||||
|
Underwriting income (loss)
|
$
|
2,813
|
$
|
2,741
|
||||
|
Loss ratio
|
60.4
|
%
|
59.5
|
%
|
||||
|
Expense ratio
|
37.1
|
%
|
38.0
|
%
|
||||
|
Combined ratio
|
97.5
|
%
|
97.5
|
%
|
||||
|
Year Ended December 31,
|
||||||||
|
2025
|
2024
|
|||||||
|
(Restated)
|
||||||||
|
(In thousands)
|
||||||||
|
Medicare Supplement
|
$
|
75,360
|
$
|
71,766
|
||||
|
Group life
|
12,559
|
14,270
|
||||||
|
Individual life
|
5,600
|
5,922
|
||||||
|
Group accident and health
|
9,178
|
11,469
|
||||||
|
Other individual health
|
8,941
|
7,472
|
||||||
|
Total
|
$
|
111,638
|
$
|
110,899
|
||||
| Item 7A. |
Quantitative and Qualitative Disclosures About Market Risk
|
| Item 8. |
Financial Statements and Supplementary Data
|
| Page | |
| ATLANTIC AMERICAN CORPORATION | |
| Report of Independent Registered Public Accounting Firm ( | 26 |
| 29 | |
| 30 | |
| 31 | |
| 32 | |
| 33 | |
| 34 |

|
December 31,
|
||||||||
|
2025
|
2024
|
|||||||
|
(Restated)
|
||||||||
|
(In thousands, except share and per share data)
|
||||||||
|
ASSETS
|
||||||||
|
Cash and cash equivalents
|
$
|
|
$
|
|
||||
|
Investments:
|
||||||||
| Fixed maturities, available-for-sale, at fair value (amortized cost: $ |
|
|
||||||
| Equity securities, at fair value (cost: $ |
|
|
||||||
| Other invested assets (cost: $ |
|
|
||||||
|
Policy loans
|
|
|
||||||
|
Real estate
|
|
|
||||||
| Investment in unconsolidated trusts (cost: $ |
|
|
||||||
|
Total investments
|
|
|
||||||
|
Receivables:
|
||||||||
| Reinsurance (net of allowance for uncollectible reinsurance of $ |
|
|
||||||
| Insurance premiums and other (net of allowance for expected credit losses $ |
|
|
||||||
|
Deferred income taxes, net
|
||||||||
|
Deferred acquisition costs
|
|
|
||||||
|
Other assets
|
|
|
||||||
|
Intangibles
|
|
|
||||||
|
Total assets
|
$
|
|
$
|
|
||||
|
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
||||||||
|
Insurance reserves and policyholder funds
|
||||||||
|
Future policy benefits
|
$
|
|
$
|
|
||||
|
Unearned premiums
|
|
|
||||||
|
Losses and claims
|
|
|
||||||
|
Other policy liabilities
|
|
|
||||||
|
Total insurance reserves and policyholder funds
|
|
|
||||||
|
Accounts payable and accrued expenses
|
|
|
||||||
|
Revolving credit facility
|
|
|
||||||
|
Junior subordinated debenture obligations, net
|
|
|
||||||
|
Total liabilities
|
|
|
||||||
|
Commitments and contingencies (Note 19)
|
||||||||
|
Shareholders’ equity:
|
||||||||
| Preferred stock, $ |
|
|
||||||
| Common stock, $ |
|
|
||||||
|
Additional paid-in capital
|
|
|
||||||
|
Retained earnings
|
|
|||||||
|
Accumulated other comprehensive loss
|
( |
)
|
( |
)
|
||||
|
Unearned stock grant compensation
|
|
( |
)
|
|||||
| Treasury stock, at cost, |
( |
) |
( |
) |
||||
|
Total shareholders’ equity
|
|
|
||||||
|
Total liabilities and shareholders’ equity
|
$
|
|
$
|
|
||||
|
Year Ended December 31
|
||||||||
|
2025
|
2024
|
|||||||
|
(Restated)
|
||||||||
|
(In thousands, except share and per share data)
|
||||||||
|
Revenue:
|
||||||||
|
Insurance premiums, net
|
$
|
|
$
|
|
||||
|
Net investment income
|
|
|
||||||
|
Realized investment gains (losses), net
|
( |
)
|
|
|||||
|
Unrealized gains (losses) on equity securities, net
|
|
( |
)
|
|||||
|
Other income
|
|
|
||||||
|
Total revenue
|
|
|
||||||
|
|
||||||||
|
Benefits and expenses:
|
||||||||
|
Insurance benefits and losses incurred
|
|
|
||||||
|
Future policy benefits remeasurement gain
|
( |
)
|
( |
)
|
||||
|
Commissions and underwriting expenses
|
|
|
||||||
|
Interest expense
|
|
|
||||||
|
Other expense
|
|
|
||||||
|
Total benefits and expenses
|
|
|
||||||
|
|
||||||||
|
Income (loss) before income taxes
|
|
( |
)
|
|||||
|
Income tax expense (benefit)
|
|
( |
)
|
|||||
|
Net income (loss)
|
|
( |
)
|
|||||
|
Preferred stock dividends
|
( |
)
|
( |
)
|
||||
|
Net income (loss) applicable to common shareholders
|
$
|
|
$
|
( |
)
|
|||
|
Earnings (loss) per common share (basic)
|
|
( |
)
|
|||||
|
Earnings (loss) per common share (diluted)
|
|
( |
)
|
|||||
|
Year Ended December 31
|
||||||||
|
2025
|
2024
|
|||||||
|
(Restated)
|
||||||||
|
(In thousands)
|
||||||||
|
Net income (loss)
|
$
|
|
$
|
( |
)
|
|||
|
Other comprehensive gain:
|
||||||||
|
Gross unrealized holding gain (loss) on available-for-sale fixed maturities
|
|
( |
)
|
|||||
|
Reclassification adjustment for net realized gains (losses) included in net income (loss)
|
|
( |
)
|
|||||
|
Change in future policy benefit due to change in discount rate
|
( |
)
|
|
|||||
|
Subtotal
|
|
|
||||||
|
|
||||||||
|
Related income tax (expense) benefit
|
( |
)
|
( |
)
|
||||
|
Subtotal
|
( |
)
|
( |
)
|
||||
|
|
||||||||
|
Total other comprehensive income, net of tax
|
|
|
||||||
|
Total comprehensive income
|
$
|
|
$
|
|
||||
|
Year Ended December 31,
|
||||||||
|
2025
|
2024
|
|||||||
|
(Restated)
|
||||||||
|
(In thousands, except share and per share data)
|
||||||||
|
Preferred stock:
|
||||||||
|
Balance, beginning of year
|
$
|
|
$
|
|
||||
|
Balance, end of year
|
|
|
||||||
|
Common stock:
|
||||||||
|
Balance, beginning of year
|
|
|
||||||
|
Balance, end of year
|
|
|
||||||
|
Additional paid-in capital:
|
||||||||
|
Balance, beginning of year
|
|
|
||||||
|
Balance, end of year
|
|
|
||||||
|
Retained earnings:
|
||||||||
|
Balance, beginning of year
|
|
|
||||||
|
Cumulative effect from the adoption of new accounting standards, net of tax
|
) |
|||||||
|
Net income (loss)
|
|
( |
) |
|||||
|
Dividends on common stock
|
( |
)
|
( |
) |
||||
|
Dividends accrued on preferred stock
|
( |
)
|
( |
) |
||||
|
Balance, end of year
|
|
|||||||
|
Accumulated other comprehensive loss:
|
||||||||
|
Balance, beginning of year
|
( |
)
|
( |
) |
||||
|
Cumulative effect from the adoption of new accounting standards, net of tax
|
||||||||
|
Other comprehensive income, net of tax
|
|
|
||||||
|
Balance, end of year
|
( |
)
|
( |
) |
||||
|
Unearned stock grant compensation:
|
||||||||
|
Balance, beginning of year
|
( |
)
|
( |
) |
||||
|
Amortization of unearned compensation
|
|
|
||||||
|
Balance, end of year
|
|
( |
) |
|||||
|
Treasury stock:
|
||||||||
|
Balance, beginning of year
|
( |
)
|
( |
) |
||||
|
Net shares acquired related to employee share-based compensation plans
|
( |
)
|
( |
) |
||||
|
Balance, end of year
|
( |
)
|
( |
) |
||||
|
Total shareholders’ equity
|
$
|
|
$
|
|||||
|
Dividends declared on common stock per share
|
$
|
|
$
|
|
||||
|
Common shares outstanding:
|
||||||||
|
Balance, beginning of year
|
|
|
||||||
|
Net shares acquired under employee share-based compensation plans
|
( |
)
|
( |
) |
||||
|
Balance, end of year
|
|
|
||||||
|
Year Ended December 31,
|
||||||||
|
2025
|
2024
|
|||||||
|
|
(Restated)
|
|||||||
|
|
(In thousands)
|
|||||||
|
Cash flows from operating activities:
|
||||||||
|
Net income (loss)
|
$
|
|
$
|
( |
)
|
|||
|
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
|
||||||||
|
Amortization of deferred acquisition costs
|
|
|
||||||
|
Acquisition costs deferred
|
( |
)
|
( |
)
|
||||
|
Realized investment gains, net
|
( |
)
|
( |
)
|
||||
|
Other than temporary impairment loss on available for sale securities
|
|
|
||||||
|
Unrealized (gains) losses on equity securities, net
|
( |
)
|
|
|||||
|
Losses from equity method investees
|
|
|
||||||
|
Compensation expense related to share awards
|
|
|
||||||
|
Benefit for credit losses
|
( |
)
|
( |
)
|
||||
|
Depreciation and amortization
|
|
|
||||||
|
Deferred income tax benefit
|
( |
)
|
( |
)
|
||||
|
(Increase) decrease in receivables, net
|
( |
)
|
|
|
||||
|
Increase in insurance reserves and policyholder funds
|
|
|
||||||
|
Increase in accounts payable and accrued expenses
|
|
|
||||||
|
Other, net
|
( |
)
|
( |
)
|
||||
|
Net cash provided by operating activities
|
|
|
||||||
|
|
||||||||
|
Cash flows from investing activities:
|
||||||||
|
Proceeds from investments sold and policy loans redeemed
|
|
|
||||||
|
Proceeds from investments matured, called or redeemed
|
|
|
||||||
|
Investments purchased
|
( |
)
|
( |
)
|
||||
|
Additions to property and equipment
|
( |
)
|
( |
)
|
||||
|
Net cash (used in) provided by investing activities
|
( |
)
|
|
|||||
|
|
||||||||
|
Cash flows from financing activities:
|
||||||||
|
Payment of dividends on Series D preferred stock
|
( |
)
|
( |
)
|
||||
|
Payment of dividends on common stock
|
( |
)
|
( |
)
|
||||
|
Treasury stock acquired — net employee share-based compensation
|
( |
)
|
( |
)
|
||||
|
Proceeds from revolving credit facility, net
|
|
|
||||||
|
Net cash provided by financing activities
|
|
|
||||||
|
|
||||||||
|
Net increase in cash
|
|
|
||||||
|
Cash and cash equivalents at beginning of year
|
|
|
||||||
|
Cash and cash equivalents at end of year
|
|
$
|
|
|||||
|
Supplemental cash flow information:
|
||||||||
|
Cash paid for interest
|
$
|
|
$
|
|
||||
|
Cash paid for federal income taxes
|
$
|
|
$
|
|
||||
|
Cash paid for state income taxes
|
$
|
|
$
|
|
||||
| December 31, 2023 | December 31, 2023 | |||||||||||
| As Previously Reported | Revision Impacts | As Revised | ||||||||||
| (In thousands) | ||||||||||||
|
ASSETS
|
||||||||||||
|
Receivables:
|
||||||||||||
|
Insurance premiums and other
|
$ | $ | ( | ) | $ | |||||||
|
Deferred income taxes, net
|
||||||||||||
|
Total assets
|
( | ) | ||||||||||
|
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
||||||||||||
|
Accounts payable and accrued expenses
|
( | ) | ||||||||||
|
Total liabilities
|
( | ) | ||||||||||
|
Shareholders’ equity:
|
||||||||||||
|
Retained earnings
|
( | ) | ||||||||||
|
Total shareholders’ equity
|
( | ) | ||||||||||
|
Total liabilities and shareholders’ equity
|
$ | $ | ( | ) | $ | |||||||
| December 31, 2024 | ||||||||||||
| As Previously Reported | Revision Impacts | As Revised | ||||||||||
| (In thousands) | ||||||||||||
|
ASSETS
|
||||||||||||
|
Receivables:
|
||||||||||||
|
Insurance premiums
|
$ | $ | ( | ) | $ | |||||||
|
Deferred income taxes, net
|
||||||||||||
|
Total assets
|
( | ) | ||||||||||
|
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
||||||||||||
|
Accounts payable and other accrued expenses
|
( | ) | ||||||||||
|
Total liabilities
|
( | ) | ||||||||||
|
Shareholders’ equity:
|
||||||||||||
|
Retained earnings
|
( | ) | ||||||||||
|
Total shareholders’ equity
|
( | ) | ||||||||||
|
Total liabilities and shareholders’ equity
|
$ | $ | ( | ) | $ | |||||||
| Year Ended December 31, 2024 | ||||||||||||
| As Previously Reported | Revision Impacts | As Revised | ||||||||||
| (In thousands, except share and per share data) | ||||||||||||
|
Revenue:
|
||||||||||||
|
Insurance premiums, net
|
$ | $ | ( | ) | $ | |||||||
|
Total revenue
|
( | ) | ||||||||||
|
Loss before income taxes
|
( | ) | ( | ) | ( | ) | ||||||
|
Income tax benefit
|
( | ) | ( | ) | ( | ) | ||||||
|
Net loss
|
( | ) | ( | ) | ( | ) | ||||||
|
Net loss applicable to common shareholders
|
$ | ( | ) | $ | ( | ) | $ | ( | ) | |||
|
Earnings (loss) per common share (basic)
|
$ | ( | ) | $ | ( | ) | $ | ( | ) | |||
|
Earnings (loss) per common share (diluted)
|
$ | ( | ) | $ | ( | ) | $ | ( | ) | |||
| Year Ended December 31, 2024 | ||||||||||||
| As Previously Reported | Revision Impacts | As Revised | ||||||||||
| (In thousands) | ||||||||||||
|
Net loss
|
$ | ( | ) | $ | ( | ) | $ | ( | ) | |||
|
Other comprehensive gain (loss):
|
||||||||||||
|
Future policy benefit discount rate remeasurement gain (loss)
|
- | | ||||||||||
|
Subtotal
|
( | ) | ( | ) | ||||||||
|
Related income tax effect
|
||||||||||||
|
Subtotal
|
||||||||||||
|
Total other comprehensive income, net of tax
|
( | ) | | ( | ) | |||||||
|
Total comprehensive income
|
$ | ( | ) | $ | ( | ) | $ | ( | ) | |||
| Year Ended December 31, 2024 | ||||||||||||
| As Previously Reported | Revision Impacts | As Revised | ||||||||||
|
(In thousands)
|
||||||||||||
|
Retained earnings:
|
||||||||||||
|
Balance, beginning of year
|
$ | $ | ( | ) | $ | |||||||
|
Net loss
|
( | ) | ( | ) | ( | ) | ||||||
|
Balance, end of year
|
( | ) | ||||||||||
|
Total shareholders’ equity
|
$ | $ | ( | ) | $ | |||||||
| Year Ended December 31, 2024 | ||||||||||||
| As Previously Reported | Revision Impacts | As Revised | ||||||||||
| (In thousands) | ||||||||||||
|
Cash flows from operating activities:
|
||||||||||||
|
Net loss
|
$ | ( | ) | $ | ( | ) | $ | ( | ) | |||
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
||||||||||||
|
Deferred income tax benefit
|
( | ) | ( | ) | ( | ) | ||||||
|
Increase in receivables, net
|
( | ) | ( | ) | ||||||||
|
(Decrease) increase in accounts payable and accrued expenses
|
( | ) | ||||||||||
|
Net cash provided by operating activities
|
$ | $ | | $ | ||||||||
| (In thousands) |
Reinsurance Recoverables |
Deferred Income Tax Asset |
Deferred Acquisition Costs |
Future Policy Benefits |
Unearned Premiums |
Other Policy Liabilities |
Retained Earnings |
Accumulated Other Comprehensive Income (Loss) | ||||||||||||||||||||||||
|
Balance as of December 31, 2023 (as
revised)
|
$ | $ | $ | $ | $ | $ | $ | $ | ( | ) | ||||||||||||||||||||||
|
Reclassification of annuities
|
( | ) | ||||||||||||||||||||||||||||||
|
Reclassification of certain group accident and health products
|
( | ) | ( | ) | ( | ) | ||||||||||||||||||||||||||
|
Reclassifications and adjustments for the cumulative effect of adoption on assets and liabilities
|
( | ) | ( | ) | ||||||||||||||||||||||||||||
|
Impact from capping Transition Date net premium ratio
|
( | ) | ||||||||||||||||||||||||||||||
|
Effect of remeasurement of future policy benefits to an upper-medium grade discount rate
|
( | ) | ( | ) | ||||||||||||||||||||||||||||
|
Adjusted balance as of January 1, 2024, gross of reinsurance
|
$ | $ | $ | $ | $ | $ | $ | $ | ( | ) | ||||||||||||||||||||||
| December 31, 2024 | ||||||||||||
|
As Revised
|
LDTI Adoption Impacts
|
As Adjusted
| ||||||||||
| (In thousands) | ||||||||||||
|
ASSETS
|
||||||||||||
|
Receivables:
|
||||||||||||
|
Reinsurance recoverables
|
$ | $ | ( | ) | $ | |||||||
|
Deferred income taxes, net
|
( | ) | ||||||||||
|
Deferred acquisition costs
|
( | ) | ||||||||||
|
Other assets
|
( | ) | ||||||||||
|
Total assets
|
( | ) | ||||||||||
|
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
||||||||||||
|
Insurance reserves and policyholder funds
|
||||||||||||
|
Future policy benefits
|
( | ) | ||||||||||
|
Unearned premiums
|
( | ) | ||||||||||
|
Other policy liabilities
|
||||||||||||
|
Total insurance reserves and policyholder funds
|
( | ) | ||||||||||
|
Total liabilities
|
( | ) | ||||||||||
|
Shareholders’ equity:
|
||||||||||||
|
Retained earnings
|
( | ) | ||||||||||
|
Accumulated other comprehensive loss
|
( | ) | ( | ) | ||||||||
|
Total shareholders’ equity
|
||||||||||||
|
Total liabilities and shareholders’ equity
|
$ | $ | ( | ) | $ | |||||||
|
Year Ended December 31, 2024
|
||||||||||||
| As Revised | LDTI Adoption Impacts | As Adjusted | ||||||||||
|
(In thousands, except share and per share data)
|
||||||||||||
|
Revenue:
|
||||||||||||
| Insurance premiums, net | $ | $ | (208 | ) | $ | |||||||
|
Total revenue
|
||||||||||||
|
Benefits and expenses:
|
||||||||||||
|
Insurance benefits and losses incurred
|
( | ) | ||||||||||
|
Future policy benefits remeasurement (gain) loss
|
- | ( | ) | ( | ) | |||||||
|
Commissions and underwriting expenses
|
||||||||||||
|
Total benefits and expenses
|
( | ) | ||||||||||
|
Loss before income taxes
|
( | ) | ( | ) | ||||||||
|
Income tax benefit
|
( | ) | ( | ) | ||||||||
|
Net loss
|
( | ) | ( | ) | ||||||||
|
Net loss applicable to common shareholders
|
$ | ( | ) | $ | $ | ( | ) | |||||
|
Earnings (loss) per common share (basic)
|
$ | ( | ) | $ | $ | ( | ) | |||||
|
Earnings (loss) per common share (diluted)
|
$ | ( | ) | $ | $ | ( | ) | |||||
| Year Ended December 31, 2024 | ||||||||||||
| As Revised | LDTI Adoption Impacts | As Adjusted | ||||||||||
| (In thousands) | ||||||||||||
|
Net loss
|
( | ) | ( | ) | ||||||||
|
Other comprehensive gain (loss):
|
||||||||||||
|
Future policy benefit discount rate remeasurement gain (loss)
|
- | |||||||||||
|
Subtotal
|
( | ) | ||||||||||
|
Related income tax effect
|
( | ) | ( | ) | ||||||||
|
Subtotal
|
( | ) | ( | ) | ||||||||
|
Total other comprehensive income, net of tax
|
( | ) | ||||||||||
|
Total comprehensive income
|
( | ) | $ | |||||||||
| Year Ended December 31, 2024 | ||||||||||||
| As Revised | LDTI Adoption Impacts | As Adjusted | ||||||||||
|
(In thousands)
|
||||||||||||
|
Retained earnings:
|
||||||||||||
|
Balance, beginning of year
|
$ | $ | ( | ) | $ | |||||||
| Net loss | ( | ) | ( | ) | ||||||||
|
Balance, end of year
|
( | ) | ||||||||||
|
Accumulated other comprehensive loss:
|
||||||||||||
|
Balance, beginning of year
|
( | ) | ( | ) | ||||||||
|
Other comprehensive income (loss), net of tax
|
( | ) | ||||||||||
|
Balance, end of year
|
( | ) | ( | ) | ||||||||
|
Total shareholders’ equity
|
$ | $ | $ | |||||||||
| Year Ended December 31, 2024 | ||||||||||||
| As Revised | LDTI Adoption Impacts | As Adjusted | ||||||||||
| (In thousands) | ||||||||||||
|
Cash flows from operating activities:
|
||||||||||||
|
Net loss
|
( | ) | $ | ( | ) | |||||||
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
||||||||||||
|
Amortization of deferred acquisition costs
|
||||||||||||
|
Acquisition costs deferred
|
( | ) | ( | ) | ( | ) | ||||||
|
Benefit provision for credit losses
|
( | ) | ( | ) | ||||||||
|
Deferred income tax benefit
|
( | ) | ( | ) | ||||||||
|
Increase in receivables, net
|
( | ) | ||||||||||
|
Increase in insurance reserves and policyholder funds
|
( | ) | ||||||||||
|
Net cash provided by operating activities
|
$ | $ | | $ | ||||||||
|
2025
|
||||||||||||||||||||
|
Estimated
Fair Value
|
Gross
Unrealized
Gains
|
Gross
Unrealized
Losses
|
Allowance
for
Credit
Losses
|
Amortized
Cost
|
||||||||||||||||
|
Fixed maturity securities:
|
||||||||||||||||||||
|
Bonds:
|
||||||||||||||||||||
|
U.S. Treasury securities and obligations of U.S. Government agencies and authorities
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||
|
Loan backed and structured securities
|
|
|
|
|
|
|||||||||||||||
|
Obligations of states and political subdivisions
|
|
|
|
|
|
|||||||||||||||
|
Corporate securities:
|
||||||||||||||||||||
|
Utilities and telecom
|
|
|
|
|
|
|||||||||||||||
|
Financial services
|
|
|
|
|
|
|||||||||||||||
|
Other business – diversified
|
|
|
|
|
|
|||||||||||||||
|
Other consumer – diversified
|
|
|
|
|
|
|||||||||||||||
|
Total corporate securities
|
|
|
|
|
|
|||||||||||||||
|
Redeemable preferred stocks:
|
||||||||||||||||||||
|
Other consumer – diversified
|
|
|
|
|
|
|||||||||||||||
|
Total redeemable preferred stocks
|
|
|
|
|
|
|||||||||||||||
|
Total fixed maturity securities
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||
|
2024
|
||||||||||||||||||||
|
Estimated
Fair Value
|
Gross
Unrealized
Gains
|
Gross
Unrealized
Losses
|
Allowance
for
Credit
Losses
|
Amortized
Cost
|
||||||||||||||||
|
Fixed maturity securities:
|
||||||||||||||||||||
|
Bonds:
|
||||||||||||||||||||
|
U.S. Treasury securities and obligations of U.S. Government agencies and authorities
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||
|
Loan backed and structures securities
|
|
|
|
|
|
|||||||||||||||
|
Obligations of states and political subdivisions
|
|
|
|
|
|
|||||||||||||||
|
Corporate securities:
|
||||||||||||||||||||
|
Utilities and telecom
|
|
|
|
|
|
|||||||||||||||
|
Financial services
|
|
|
|
|
|
|||||||||||||||
|
Other business – diversified
|
|
|
|
|
|
|||||||||||||||
|
Other consumer – diversified
|
|
|
|
|
|
|||||||||||||||
|
Total corporate securities
|
|
|
|
|
|
|||||||||||||||
|
Redeemable preferred stocks:
|
||||||||||||||||||||
|
Other consumer – diversified
|
|
|
|
|
|
|||||||||||||||
|
Total redeemable preferred stocks
|
|
|
|
|
|
|||||||||||||||
|
Total fixed maturity securities
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||
|
2025
|
||||||||||||||||
|
Estimated
Fair Value
|
Gross
Unrealized
Gains
|
Gross
Unrealized
Losses
|
Cost
|
|||||||||||||
|
Equity securities:
|
||||||||||||||||
|
Common and non-redeemable preferred stocks:
|
||||||||||||||||
|
Financial services
|
|
|
|
|
||||||||||||
|
Communications
|
|
|
|
|
||||||||||||
|
Total equity securities
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
2024
|
||||||||||||||||
|
Estimated
Fair Value
|
Gross
Unrealized
Gains
|
Gross
Unrealized
Losses
|
Cost
|
|||||||||||||
|
Equity securities:
|
||||||||||||||||
|
Common and non-redeemable preferred stocks:
|
||||||||||||||||
|
Financial services
|
|
|
|
|
||||||||||||
|
Communications
|
|
|
|
|
||||||||||||
|
Total equity securities
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
2025
|
2024
|
|||||||||||||||
|
Carrying Value
|
Amortized Cost
|
Carrying Value
|
Amortized Cost
|
|||||||||||||
|
Due in one year or less
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Due after one year through five years
|
|
|
|
|
||||||||||||
|
Due after five years through ten years
|
|
|
|
|
||||||||||||
|
Due after ten years
|
|
|
|
|
||||||||||||
|
Asset backed securities
|
|
|
|
|
||||||||||||
|
Totals
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
2025
|
||||||||||||||||||||||||
|
Less than 12 months
|
12 months or longer
|
Total
|
||||||||||||||||||||||
|
Fair
Value
|
Unrealized
Losses
|
Fair
Value
|
Unrealized
Losses
|
Fair
Value
|
Unrealized
Losses
|
|||||||||||||||||||
|
U.S. Treasury securities and obligations of U.S. Government agencies and authorities
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||
|
Loan backed and structured securities
|
|
|
|
|
|
|
||||||||||||||||||
|
Obligations of states and political subdivisions
|
|
|
|
|
|
|
||||||||||||||||||
|
Corporate securities
|
|
|
|
|
|
|
||||||||||||||||||
|
Total temporarily impaired securities
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||
|
2024
|
||||||||||||||||||||||||
|
Less than 12 months
|
12 months or longer
|
Total
|
||||||||||||||||||||||
|
Fair
Value
|
Unrealized
Losses
|
Fair
Value
|
Unrealized
Losses
|
Fair
Value
|
Unrealized
Losses
|
|||||||||||||||||||
|
U.S. Treasury securities and obligations of U.S. Government agencies and authorities
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||
|
Loan backed and structured securities
|
|
|
|
|
|
|
||||||||||||||||||
|
Obligations of states and political subdivisions
|
|
|
|
|
|
|
||||||||||||||||||
|
Corporate securities
|
|
|
|
|
|
|
||||||||||||||||||
|
Redeemable preferred stocks
|
|
|
|
|
|
|
||||||||||||||||||
|
Total temporarily impaired securities
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||
|
2025
|
2024
|
|||||||
|
Fixed maturity securities
|
$
|
|
$
|
|
||||
|
Equity securities
|
|
|
||||||
|
Other
|
|
|
||||||
| |
|
|||||||
|
Investment expenses
|
|
|
||||||
|
Net investment income
|
$
|
|
$
|
|
||||
|
2025
|
||||||||||||||||
|
Fixed
Maturity
Securities
|
Equity
Securities
|
Other
Invested
Assets
|
Total
|
|||||||||||||
|
Gains
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Losses
|
( |
)
|
|
|
( |
)
|
||||||||||
|
Impairment losses
|
( |
)
|
|
|
( |
)
|
||||||||||
|
Realized investment losses, net
|
$
|
( |
)
|
$
|
|
$
|
|
$
|
( |
)
|
||||||
|
2024
|
||||||||||||||||
|
Fixed
Maturity
Securities
|
Equity
Securities
|
Other
Invested
Assets
|
Total
|
|||||||||||||
|
Gains
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Losses
|
( |
)
|
|
|
( |
)
|
||||||||||
|
Realized investment gains, net
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
2025
|
2024
|
|||||||
|
Sales proceeds
|
$
|
|
$
|
|
||||
|
Gross gains
|
|
|
||||||
|
Gross losses
|
|
|
||||||
|
2025
|
2024
|
|||||||
|
Sales proceeds
|
$
|
|
$
|
|
||||
|
Gross gains
|
|
|
||||||
|
Gross losses
|
|
|
||||||
|
2025
|
2024
|
|||||||
|
Net realized and unrealized gains (losses) recognized during the period on equity securities
|
$
|
|
$
|
( |
)
|
|||
|
Less: Net realized gains recognized during the period on equity securities sold during the period
|
|
|
||||||
|
Unrealized gains (losses) on equity securities, net
|
$
|
|
$
|
( |
)
|
|||
| Level 1 |
Observable inputs that reflect quoted prices for identical assets or liabilities in active markets that the Company has the ability to access at the measurement date. The Company’s financial instruments valued using Level 1
criteria include cash equivalents and exchange traded common stocks.
|
| Level 2 |
Observable inputs, other than quoted prices included in Level 1, for an asset or liability or prices for similar assets or liabilities. The Company’s financial instruments valued using Level 2 criteria include significantly most of
its fixed maturity securities, which consist of U.S. Treasury securities, U.S. Government securities, obligations of states and political subdivisions, and certain corporate fixed maturity securities, as well as its non-redeemable
preferred stocks. In determining fair value measurements of its fixed maturity securities and non-redeemable preferred stocks using Level 2 criteria, the Company utilizes data from outside sources, including nationally recognized
pricing services and broker/dealers. Prices for the majority of the Company’s Level 2 fixed maturity securities and non-redeemable preferred stocks were determined using unadjusted prices received from pricing services that utilize
models where the significant inputs are observable (e.g., interest rates, yield curves, prepayment speeds, default rates, loss severities) or can be corroborated by observable market data.
|
| Level 3 | Valuations that are derived from techniques in which one or more of the significant inputs are unobservable (including assumptions about risk). Fair value is based on criteria that use assumptions or other data that are not readily observable from objective sources. With little or no observable market, the determination of fair values uses considerable judgment and represents the Company’s best estimate of an amount that could be realized in a market exchange for the asset or liability. The Company’s financial instruments valued using Level 3 criteria consist of one equity security. As of December 31, 2025 and December 31, 2024, the value of the equity security valued using Level 3 criteria was $ |
|
Quoted Prices in
Active Markets
for Identical Assets
(Level 1)
|
Significant
Other Observable
Inputs
(Level 2)
|
Significant
Unobservable
Inputs
(Level 3)
|
Total
|
|||||||||||||
|
Assets:
|
||||||||||||||||
|
Fixed maturity securities
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Equity securities
|
|
|
|
|
||||||||||||
|
Cash equivalents
|
|
|
|
|
||||||||||||
|
Total
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Quoted Prices in
Active Markets
for Identical Assets
(Level 1)
|
Significant
Other Observable
Inputs
(Level 2)
|
Significant
Unobservable
Inputs
(Level 3)
|
Total
|
|||||||||||||
|
Assets:
|
||||||||||||||||
|
Fixed maturity securities
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Equity securities
|
|
|
|
|
||||||||||||
|
Cash equivalents
|
|
|
|
|
||||||||||||
|
Total
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Level in
Fair Value
Hierarchy(1)
|
2025
|
2024
|
|||||||||||||||||
|
Carrying
Amount
|
Estimated
Fair Value
|
Carrying
Amount
|
Estimated
Fair Value
|
||||||||||||||||
|
Assets:
|
|||||||||||||||||||
|
Cash and cash equivalents
|
(1)
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||
|
Fixed maturity securities
|
Level 2
|
|
|
|
|
||||||||||||||
|
Equity securities
|
(1)
|
|
|
|
|
|
|||||||||||||
|
Policy loans
|
Level 3
|
|
|
|
|
||||||||||||||
|
Liabilities:
|
|||||||||||||||||||
|
Junior subordinated debentures, net
|
Level 2
|
|
|
|
|
||||||||||||||
|
Revolving credit facility
|
Level 2
|
|
|
|
|
||||||||||||||
|
Other policy liabilities -annuities
|
Level 3(2)
|
|
|
|
|
||||||||||||||
| (1) | |
| (2) | |
|
At and year ended December
31, 2025
|
||||||||
|
Reinsurance
Recoverables,
Net of
Allowance
for
Expected
Credit Losses
|
Allowance
for
Expected
Credit
Losses
|
|||||||
|
Balance, beginning of period
|
$
|
|
$
|
|
||||
|
Current period change for estimated uncollectible reinsurance
|
( |
)
|
||||||
|
Write-offs of uncollectible reinsurance recoverables
|
|
|||||||
|
Balance, end of period
|
$
|
|
$
|
|
||||
|
At and year ended December
31, 2024 (Restated)
|
||||||||
|
Reinsurance
Recoverables,
Net of
Allowance
for
Expected
Credit Losses
|
Allowance
for
Expected
Credit
Losses
|
|||||||
|
Balance, beginning of period
|
$
|
|
$
|
|
||||
|
Current period change for estimated uncollectible reinsurance
|
|
|||||||
|
Write-offs of uncollectible reinsurance recoverables
|
|
|||||||
|
Balance, end of period
|
$
|
|
$
|
|
||||
|
At and year ended December
31, 2025
|
||||||||
|
Insurance
Premiums
and
Other, Net
of Expected
Credit
Losses
|
Allowance
for
Expected
Credit
Losses
|
|||||||
|
Balance, beginning of period
|
$
|
|
$
|
|
||||
|
Current period change for expected credit losses
|
( |
)
|
||||||
|
Write-offs of uncollectible insurance premiums and other receivables
|
|
|||||||
|
Balance, end of period
|
$
|
|
$
|
|
||||
|
At and year ended December
31, 2024 (restated)
|
||||||||
|
Insurance
Premiums
and
Other, Net
of Expected
Credit
Losses
|
Allowance
for
Expected
Credit
Losses
|
|||||||
|
Balance, beginning of period
|
$
|
|
$
|
|
||||
|
Current period change for expected credit losses
|
( |
)
|
||||||
|
Write-offs of uncollectible insurance premiums and other receivables
|
|
|||||||
|
Balance, end of period
|
$
|
|
$
|
|
||||
|
2025
|
2024 (Restated)
|
|||||||||||||||||||||||
|
American
Southern
|
Bankers
Fidelity
|
Total
|
American
Southern
|
Bankers
Fidelity
|
Total
|
|||||||||||||||||||
|
Deferred policy acquisition costs:
|
||||||||||||||||||||||||
|
Balance, beginning of year
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||
|
Capitalization
|
|
|
|
|
|
|
||||||||||||||||||
|
Amortization
|
( |
)
|
( |
)
|
( |
)
|
( |
)
|
( |
)
|
( |
)
|
||||||||||||
|
Balance, end of year(1)
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||
|
2025
|
||||||||||||||||||||||||
|
Automobile
Liability
|
General
Liability
|
Inland
Marine
|
Automobile
Physical
Damage
|
Surety
|
Total
|
|||||||||||||||||||
|
DAC balance as of the beginning of the year
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||
|
Capitalized expenses
|
|
|
|
|
|
|
||||||||||||||||||
|
Amortization of DAC
|
( |
)
|
( |
)
|
( |
)
|
( |
)
|
( |
)
|
( |
)
|
||||||||||||
|
DAC balance as of the valuation date
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||
|
2024
|
||||||||||||||||||||||||
|
Automobile
Liability
|
General
Liability |
Inland
Marine
|
Automobile
Physical
Damage
|
Surety
|
Total
|
|||||||||||||||||||
|
DAC balance as of the beginning of the year
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||
|
Capitalized expenses
|
|
|
|
|
|
|
||||||||||||||||||
|
Amortization of DAC
|
( |
)
|
( |
)
|
( |
)
|
( |
)
|
( |
)
|
( |
)
|
||||||||||||
|
DAC balance as of the valuation date
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||
|
2025
|
||||||||||||||||||||||||
|
Individual
Life
|
Group
Whole Life
|
Medicare
Supplement
|
Other
Individual
Accident
and Health
|
Group
Accident
and Health
|
Total
|
|||||||||||||||||||
|
DAC balance as of the beginning of the year
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||
|
Capitalized expenses
|
|
|
|
|
|
|
||||||||||||||||||
|
Amortization of DAC
|
( |
)
|
( |
)
|
( |
)
|
( |
)
|
( |
)
|
( |
)
|
||||||||||||
|
DAC balance as of the valuation date
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||
|
2024
|
||||||||||||||||||||||||
|
(Restated)
|
||||||||||||||||||||||||
|
Individual
Life
|
Group
Whole Life
|
Medicare
Supplement
|
Other
Individual
Accident
and Health
|
Group
Accident
and Health
|
Total
|
|||||||||||||||||||
|
DAC balance as of the beginning of the year
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||
|
Capitalized expenses
|
|
|
|
|
|
|
||||||||||||||||||
|
Amortization of DAC
|
( |
)
|
( |
)
|
( |
)
|
( |
)
|
( |
)
|
( |
)
|
||||||||||||
|
DAC balance as of the valuation date
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||
|
2025
|
2024
|
|||||||
|
(Dollar amounts in thousands)
|
(Restated) | |||||||
|
Individual life
|
$
|
|
$
|
|
||||
|
Group life
|
|
|
||||||
|
Medicare Supplement
|
|
|
||||||
|
Other individual health
|
|
|
||||||
|
Net liability for future policy benefits
|
|
|
||||||
|
Less: reinsurance recoverable
|
( |
)
|
( |
)
|
||||
|
Net liability for future policy benefits, net of reinsurance recoverable
|
$
|
|
$
|
|
||||
| 2025 | ||||||||||||||||||||
| (Dollar amounts in thousands) | Individual Life | Group Life | Medicare Supplement | Other Individual Health | Total | |||||||||||||||
| Present value of expected net premiums: | ||||||||||||||||||||
| Beginning balance as of January 1 | $ | | $ | | $ | | $ | | $ | | ||||||||||
| Beginning balance, at original discount rate | | | | | | |||||||||||||||
| Effect of changes in cash flow assumptions | | ( | ) | ( | ) | | ( | ) | ||||||||||||
| Effect of actual variances from expected experience | ( | ) | ( | ) | | ( | ) | | ||||||||||||
| Adjusted beginning balance | | | | | | |||||||||||||||
| Issuances | | | | | | |||||||||||||||
| Interest accretion | | | | | | |||||||||||||||
| Net premiums collected(1) | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||
| Other | ( | ) | | | ( | ) | ( | ) | ||||||||||||
| Ending balance, at original discount rate | | | | | | |||||||||||||||
| Effect of changes in discount rate assumptions | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||
| Ending balance as of December 31, | $ | | $ | | $ | | $ | | $ | | ||||||||||
| Present value of expected future policy benefits: | ||||||||||||||||||||
| Beginning balance as of January 1 | $ | | $ | | $ | | $ | | | |||||||||||
| Beginning balance, at original discount rate | | | | | | |||||||||||||||
| Effect of changes in cash flow assumptions | | ( | ) | ( | ) | ( | ) | ( | ) | |||||||||||
| Effect of actual variances from expected experience | | ( | ) | | ( | ) | | |||||||||||||
| Adjusted beginning balance | | | | | | |||||||||||||||
| Issuances | | | | | | |||||||||||||||
| Interest accretion | | | | | | |||||||||||||||
| Benefit payments | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||
| Other | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||
| Ending balance, at original discount rate | | | | | | |||||||||||||||
| Effect of changes in discount rate assumptions | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||
| Ending balance as of December 31, | $ | | $ | | $ | | $ | | $ | | ||||||||||
| Net liability for future policy benefits, before flooring adjustments | | | | | | |||||||||||||||
| Flooring adjustments(2) | | | | | | |||||||||||||||
| Net liability for future policy benefits | | | | | | |||||||||||||||
| Less: reinsurance recoverable | ( | ) | | ( | ) | | ( | ) | ||||||||||||
| Net liability for future policy benefits, net of reinsurance recoverable | $ | | $ | | $ | | $ | | $ | | ||||||||||
| Weighted average liability duration (years) | | | | | ||||||||||||||||
| (1) | |
| (2) | |
| 2024 | ||||||||||||||||||||
| (Restated) | ||||||||||||||||||||
| (Dollar amounts in thousands) | Individual Life | Group Life | Medicare Supplement | Other Individual Health | Total | |||||||||||||||
| Present value of expected net premiums: | ||||||||||||||||||||
| Beginning balance as of January 1 | $ | | $ | | $ | | $ | | $ | | ||||||||||
| Beginning balance, at original discount rate | | | | | | |||||||||||||||
| Effect of changes in cash flow assumptions | ( | ) | ( | ) | ( | ) | | ( | ) | |||||||||||
| Effect of actual variances from expected experience | | ( | ) | | ( | ) | | |||||||||||||
| Adjusted beginning balance | | | | | | |||||||||||||||
| Issuances | | | | | | |||||||||||||||
| Interest accretion | | | | | | |||||||||||||||
| Net premiums collected(1) | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||
| Other | | | | | | |||||||||||||||
| Ending balance, at original discount rate | | | | | | |||||||||||||||
| Effect of changes in discount rate assumptions | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||
| Ending balance as of December 31, | $ | | $ | | $ | | $ | | $ | | ||||||||||
| Present value of expected future policy benefits: | ||||||||||||||||||||
| Beginning balance as of January 1 | $ | | $ | | $ | | $ | | | |||||||||||
| Beginning balance, at original discount rate | | | | | | |||||||||||||||
| Effect of changes in cash flow assumptions | ( | ) | ( | ) | ( | ) | | ( | ) | |||||||||||
| Effect of actual variances from expected experience | | ( | ) | | ( | ) | | |||||||||||||
| Adjusted beginning balance | | | | | | |||||||||||||||
| Issuances | | | | | | |||||||||||||||
| Interest accretion | | | | | | |||||||||||||||
| Benefit payments | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||
| Other | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||
| Ending balance, at original discount rate | | | | | | |||||||||||||||
| Effect of changes in discount rate assumptions | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||
| Ending balance as of December 31, | $ | | $ | | $ | | $ | | $ | | ||||||||||
| Net liability for future policy benefits, before flooring adjustments | | | | | | |||||||||||||||
| Flooring adjustments(2) | | | | | ||||||||||||||||
| Net liability for future policy benefits | | | | | | |||||||||||||||
| Less: reinsurance recoverable | ( | ) | | ( | ) | | ( | ) | ||||||||||||
| Net liability for future policy benefits, net of reinsurance recoverable | $ | | $ | | $ | | $ | | $ | | ||||||||||
| Weighted average liability duration (years) | | | | | ||||||||||||||||
|
(1)
|
Net premiums represent the portion of gross premiums collected from policyholders that is necessary to fund expected benefit payments
|
|
(2)
|
Flooring adjustments are necessary when the present value of future net premiums exceeds the present value of future benefits for a given cohort. The flooring adjustment is the total of the flooring
adjustments for each cohort, if any. These adjustments ensure that the liability for future policy benefits is at least zero for all cohorts.
|
|
Year Ended December 31,
2025
|
Year Ended December 31,
2024
|
|||||
|
Individual Life
|
||||||
|
Interest accretion (locked-in) rate
|
|
%
|
|
%
|
||
|
Current discount rate
|
|
%
|
|
%
|
||
|
Group Life
|
||||||
|
Interest accretion (locked-in) rate
|
|
%
|
|
%
|
||
|
Current discount rate
|
|
%
|
|
%
|
||
|
Medicare Supplement
|
||||||
|
Interest accretion (locked-in) rate
|
|
%
|
|
%
|
||
|
Current discount rate
|
|
%
|
|
%
|
||
|
Other Individual Health
|
||||||
|
Interest accretion (locked-in) rate
|
|
%
|
|
%
|
||
|
Current discount rate
|
|
%
|
|
%
|
|
2025
|
2024
|
|||||||||||||||
|
(Dollar amounts in thousands)
|
Undiscounted
|
Discounted
|
Undiscounted
|
Discounted
|
||||||||||||
|
Individual life
|
||||||||||||||||
|
Expected future gross premiums
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Expected future benefits payments
|
|
|
|
|
||||||||||||
|
Group Life
|
||||||||||||||||
|
Expected future gross premiums
|
|
|
|
|
||||||||||||
|
Expected future benefits payments
|
|
|
|
|
||||||||||||
|
Medicare Supplement
|
||||||||||||||||
|
Expected future gross premiums
|
|
|
|
|
||||||||||||
|
Expected future benefits payments
|
|
|
|
|
||||||||||||
|
Other Individual Health
|
||||||||||||||||
|
Expected future gross premiums
|
|
|
|
|
||||||||||||
|
Expected future benefits payments
|
|
|
|
|
||||||||||||
|
2025
|
2024
|
|||||||||||||||
|
(Dollar amounts in thousands)
|
Gross
Premiums
|
Interest
Accretion(1)
|
Gross
Premiums
|
Interest
Accretion(1)
|
||||||||||||
|
Individual life
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Group Life
|
|
|
|
|
||||||||||||
|
Medicare Supplement
|
|
|
|
|
||||||||||||
|
Other Individual Health
|
|
|
|
|
||||||||||||
|
$
|
|
$
|
|
$
|
|
$
|
|
|||||||||
| (1) | |
|
2025
|
2024
|
|||||||
|
Balance at January 1
|
$
|
|
$
|
|
||||
|
Less: Reinsurance recoverable on unpaid losses
|
( |
) |
( |
) |
||||
|
Net balance at January 1
|
|
|
||||||
|
Incurred related to:
|
||||||||
|
Current year
|
|
|
||||||
|
Prior years
|
|
(1)
|
|
(2)
|
||||
|
Total incurred
|
|
|
||||||
|
Paid related to:
|
||||||||
|
Current year
|
|
|
||||||
|
Prior years
|
|
|
||||||
|
Total paid
|
|
|
||||||
|
Net balance at December 31
|
|
|
||||||
|
Plus: Reinsurance recoverable on unpaid losses
|
|
|
||||||
|
Balance at December 31
|
$
|
|
$
|
|
||||
| 2025 |
2024 |
|||||||
| (Restated) |
||||||||
|
Total incurred losses
|
$
|
|
$
|
|
||||
|
Cash surrender value and matured endowments
|
|
|
||||||
|
Benefit reserve changes
|
|
|
||||||
|
Total insurance benefits and losses incurred(1)
|
$
|
|
$
|
|
||||
|
As of December 31,
2025
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
For the Years Ended December 31,
|
IBNR
Reserves
|
Cumulative
Number of
Reported
Claims
|
||||||||||||||||||||||||||||||||||||||||||||||
|
Incurred Losses, Claims and Allocated Loss Adjustment Expenses, Net of
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Reinsurance
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Accident Year
|
2016
|
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
||||||||||||||||||||||||||||||||||||||
|
2016
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
|
|||||||||||||||||||||||||
|
2017
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||
|
2018
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||
|
2019
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
|
2020
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||
|
2021
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||
|
2022
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
|
2023
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||
|
2024
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||
|
2025
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
|
$
|
|
|||||||||||||||||||||||||||||||||||||||||||||||
|
Cumulative Paid Losses, Claims and Allocated Loss Adjustment Expenses, Net of Reinsurance
|
||||||||||||||||||||||||||||||||||||||||
|
Accident Year
|
2016
|
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
||||||||||||||||||||||||||||||
|
2016
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||||||||||
|
2017
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||
|
2018
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||
|
2019
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||
|
2020
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
|
2021
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||
|
2022
|
|
|
|
|
||||||||||||||||||||||||||||||||||||
|
2023
|
|
|
|
|||||||||||||||||||||||||||||||||||||
|
2024
|
|
|
||||||||||||||||||||||||||||||||||||||
|
2025
|
|
|||||||||||||||||||||||||||||||||||||||
|
$
|
|
|||||||||||||||||||||||||||||||||||||||
|
Liabilities for losses, claims and loss adjustment expenses, net of reinsurance
|
$
|
|
||||||||||||||||||||||||||||||||||||||
|
As of December 31,
2025
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
For the Years Ended December 31,
|
IBNR
Reserves
|
Cumulative
Number of
Reported
Claims
|
||||||||||||||||||||||||||||||||||||||||||||||
|
Incurred Losses, Claims and Allocated Loss Adjustment Expenses, Net of
Reinsurance
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Accident Year
|
2016
|
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
||||||||||||||||||||||||||||||||||||||
|
2016
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
|
|||||||||||||||||||||||||||
|
2017
|
|
|
|
|
|
|
|
|
|
$
|
|
|
||||||||||||||||||||||||||||||||||||
|
2018
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||
|
2019
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
|
2020
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||
|
2021
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||
|
2022
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
|
2023
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||
|
2024
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||
|
2025
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| |
||||||||||||||||||||||||||||||||||||||||||||||||
|
Cumulative Paid Losses, Claims and Allocated Loss Adjustment Expenses, Net of Reinsurance
|
||||||||||||||||||||||||||||||||||||||||
|
Accident Year
|
2016
|
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
||||||||||||||||||||||||||||||
|
2016
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||||||||||
|
2017
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||
|
2018
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||
|
2019
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||
|
2020
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
|
2021
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||
|
2022
|
|
|
|
|
||||||||||||||||||||||||||||||||||||
|
2023
|
|
|
|
|||||||||||||||||||||||||||||||||||||
|
2024
|
|
|
||||||||||||||||||||||||||||||||||||||
|
2025
|
|
|||||||||||||||||||||||||||||||||||||||
|
$
|
|
|||||||||||||||||||||||||||||||||||||||
|
Liabilities for losses, claims and loss adjustment expenses, net of reinsurance
|
$
|
|
||||||||||||||||||||||||||||||||||||||
|
As of December 31,
2025
|
||||||||||||||||||||||||||||
|
For the Years Ended December 31,
|
IBNR
Reserves
|
Cumulative
Number of
Reported
Claims
|
||||||||||||||||||||||||||
|
Incurred Losses, Claims and Allocated Loss Adjustment Expenses, Net of
Reinsurance |
||||||||||||||||||||||||||||
|
Accident Year
|
2021
|
2022
|
2023
|
2024
|
2025
|
|||||||||||||||||||||||
|
2021
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
|
|||||||||||||||
|
2022
|
|
|
|
|
|
|
||||||||||||||||||||||
|
2023
|
|
|
|
|
|
|||||||||||||||||||||||
|
2024
|
|
|
|
|
||||||||||||||||||||||||
|
2025
|
|
|
|
|||||||||||||||||||||||||
| |
||||||||||||||||||||||||||||
|
Cumulative Paid Losses, Claims and Allocated Loss Adjustment Expenses, Net of Reinsurance
|
||||||||||||||||||||
|
Accident Year
|
2021
|
2022
|
2023
|
2024
|
2025
|
|||||||||||||||
|
2021
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||
|
2022
|
|
|
|
|
||||||||||||||||
|
2023
|
|
|
|
|||||||||||||||||
|
2024
|
|
|
||||||||||||||||||
|
2025
|
|
|||||||||||||||||||
|
$
|
|
|||||||||||||||||||
|
Liabilities for losses, claims and loss adjustment expenses, net of reinsurance
|
$
|
|
||||||||||||||||||
|
As of December 31,
2025
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
For the Years Ended December 31,
|
IBNR
Reserves
|
Cumulative
Number of
Reported
Claims
|
||||||||||||||||||||||||||||||||||||||||||||||
|
Incurred Losses, Claims and Allocated Loss Adjustment Expenses, Net of
Reinsurance
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Accident Year
|
2016
|
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
||||||||||||||||||||||||||||||||||||||
|
2016
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
|
|||||||||||||||||||||||||||
|
2017
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||
|
2018
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
|
2019
|
|
|
|
|
|
|
|
$
|
|
|
||||||||||||||||||||||||||||||||||||||
|
2020
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||
|
2021
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||
|
2022
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
|
2023
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||
|
2024
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||
|
2025
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| |
||||||||||||||||||||||||||||||||||||||||||||||||
|
Cumulative Paid Losses, Claims and Allocated Loss Adjustment Expenses, Net of Reinsurance
|
||||||||||||||||||||||||||||||||||||||||
|
Accident Year
|
2016
|
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
||||||||||||||||||||||||||||||
|
2016
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||||||||||
|
2017
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||
|
2018
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||
|
2019
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||
|
2020
|
|
|
|
|||||||||||||||||||||||||||||||||||||
|
2021
|
|
|
|
|||||||||||||||||||||||||||||||||||||
|
2022
|
|
|
|
|||||||||||||||||||||||||||||||||||||
|
2023
|
|
|
|
|||||||||||||||||||||||||||||||||||||
|
2024
|
|
|
||||||||||||||||||||||||||||||||||||||
|
2025
|
|
|||||||||||||||||||||||||||||||||||||||
|
$
|
|
|||||||||||||||||||||||||||||||||||||||
|
All outstanding liabilities before 2016, net of reinsurance
|
|
|||||||||||||||||||||||||||||||||||||||
|
Liabilities for losses, claims and loss adjustment expenses, net of reinsurance
|
$
|
|
||||||||||||||||||||||||||||||||||||||
|
As of December 31,
2025
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
For the Years Ended December 31,
|
||||||||||||||||||||||||||||||||||||||||||||||||
IBNR
Reserves
|
Cumulative
Number of
Reported
Claims
|
|||||||||||||||||||||||||||||||||||||||||||||||
|
Incurred Losses, Claims and Allocated Loss Adjustment Expenses, Net of
Reinsurance
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Accident Year
|
2016
|
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
||||||||||||||||||||||||||||||||||||||
|
2016
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||||||||||||||
|
2017
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||
|
2018
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||
|
2019
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
|
2020
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||
|
2021
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||
|
2022
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
|
2023
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||
|
2024
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||
|
2025
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
|
$
|
|
|||||||||||||||||||||||||||||||||||||||||||||||
|
Cumulative Paid Losses, Claims and Allocated Loss Adjustment Expenses, Net of Reinsurance
|
||||||||||||||||||||||||||||||||||||||||
|
Accident Year
|
2016
|
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
||||||||||||||||||||||||||||||
|
2016
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||||||||||
|
2017
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||
|
2018
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||
|
2019
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||
|
2020
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
|
2021
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||
|
2022
|
|
|
|
|
||||||||||||||||||||||||||||||||||||
|
2023
|
|
|
|
|||||||||||||||||||||||||||||||||||||
|
2024
|
|
|
||||||||||||||||||||||||||||||||||||||
|
2025
|
|
|||||||||||||||||||||||||||||||||||||||
|
$
|
|
|||||||||||||||||||||||||||||||||||||||
|
All outstanding liabilities before 2016, net of reinsurance
|
|
|||||||||||||||||||||||||||||||||||||||
|
Liabilities for losses, claims and loss adjustment expenses, net of reinsurance
|
$
|
|
||||||||||||||||||||||||||||||||||||||
|
Average Annual Percentage Payout of Incurred Claims by Age, Net of Subrogation and Reinsurance (Unaudited)
|
||||||||||||||||||||||||||||||||||||||||
|
Reserve Line
|
1st Year
|
2nd Year
|
3rd Year
|
4th Year
|
5th Year
|
6th Year
|
7th Year
|
8th Year
|
9th Year
|
10th Year
|
||||||||||||||||||||||||||||||
|
Medicare Supplement
|
|
%
|
|
%
|
|
%
|
|
%
|
|
%
|
|
%
|
|
%
|
|
%
|
|
%
|
|
%
|
||||||||||||||||||||
|
Automobile liability
|
|
%
|
|
%
|
|
%
|
|
%
|
|
%
|
|
%
|
|
%
|
|
%
|
|
%
|
|
%
|
||||||||||||||||||||
|
Automobile physical damage
|
|
%
|
|
%
|
|
%
|
|
%
|
|
%
|
|
%
|
|
%
|
|
%
|
|
%
|
|
%
|
||||||||||||||||||||
|
General liability
|
|
%
|
|
%
|
|
%
|
|
%
|
|
%
|
|
%
|
|
%
|
|
%
|
|
%
|
|
%
|
||||||||||||||||||||
|
Surety
|
|
%
|
|
%
|
|
%
|
- |
%
|
- |
%
|
- |
%
|
- |
%
|
- |
%
|
- |
%
|
- |
%
|
||||||||||||||||||||
| Net outstanding liabilities: |
December 31, 2025 |
|||
|
Medicare Supplement
|
$
|
|
||
|
Automobile liability
|
|
|||
|
Automobile physical damage
|
|
|||
|
General liability
|
|
|||
|
Surety
|
|
|||
|
Other short-duration insurance lines(1)
|
|
|||
|
Liabilities for unpaid losses, claims and loss adjustment expenses, net of reinsurance
|
|
|||
|
Reinsurance recoverable on unpaid losses:
|
||||
|
Medicare Supplement
|
|
|||
|
Automobile liability
|
|
|||
|
Automobile physical damage
|
|
|||
|
General liability
|
|
|||
|
Other short-duration insurance lines
|
|
|||
|
Total reinsurance recoverable on unpaid losses
|
|
|||
|
Unallocated claims adjustment expenses
|
|
|||
|
Total gross liability for unpaid losses, claims and loss adjustment expenses
|
$
|
|
||
| For the Year Ended Dec 31, 2025 |
||||||||||||
| American Southern |
Bankers Fidelity |
Total |
||||||||||
|
Direct premiums written
|
$
|
|
$
|
|
$
|
|
||||||
|
Assumed premiums written
|
|
|
|
|||||||||
|
Ceded premiums written
|
( |
)
|
( |
)
|
( |
) | ||||||
|
Net premiums written
|
|
|
|
|||||||||
|
Direct premiums earned
|
|
|
|
|||||||||
|
Assumed premiums earned
|
|
|
|
|||||||||
|
Ceded premiums earned
|
( |
)
|
( |
)
|
( |
) | ||||||
|
Net premiums earned
|
|
|
|
|||||||||
|
Provision for benefits and losses incurred
|
|
|
|
|||||||||
|
Reinsurance loss recoveries
|
( |
)
|
( |
)
|
( |
) | ||||||
|
Insurance benefits and losses incurred
|
$
|
|
$
|
|
$
|
|
(1) | |||||
| For the Year Ended Dec 31, 2024 |
||||||||||||
| (Restated) | ||||||||||||
| American |
Bankers |
|||||||||||
| Southern |
Fidelity |
Total |
||||||||||
|
Direct premiums written
|
$
|
|
$
|
|
$
|
|
||||||
|
Assumed premiums written
|
|
|
|
|||||||||
|
Ceded premiums written
|
( |
)
|
( |
)
|
( |
) | ||||||
|
Net premiums written
|
|
|
|
|||||||||
|
Direct premiums earned
|
|
|
|
|||||||||
|
Assumed premiums earned
|
|
|
|
|||||||||
|
Ceded premiums earned
|
( |
)
|
( |
)
|
( |
) | ||||||
|
Net premiums earned
|
|
|
|
|||||||||
|
Provision for benefits and losses incurred
|
|
|
|
|||||||||
|
Reinsurance loss recoveries
|
( |
)
|
( |
)
|
( |
) | ||||||
|
Insurance benefits and losses incurred
|
$
|
|
$
|
|
$
|
|
(2) | |||||
| December 31, 2025 | ||||||||||||
|
American
Southern
|
Bankers
Fidelity
|
Total
|
||||||||||
|
Recoverable on unpaid losses, net of allowance
|
$
|
|
$
|
|
$
|
|
||||||
|
Recoverable on unpaid benefits
|
|
|
|
|||||||||
|
Recoverable on paid losses
|
|
|
|
|||||||||
|
Ceded benefit reserves
|
|
( |
)
|
( |
)
|
|||||||
|
Ceded unearned premiums
|
|
|
|
|||||||||
|
Ceded advanced premiums
|
|
|
|
|||||||||
|
Total reinsurance receivables
|
$
|
|
$
|
|
$
|
|
||||||
|
December 31, 2024
|
||||||||||||
|
American
Southern
|
Bankers
Fidelity
|
Total
|
||||||||||
|
Recoverable on unpaid losses, net of allowance
|
$
|
|
$
|
|
$
|
|
||||||
|
Recoverable on unpaid benefits
|
|
|
|
|||||||||
|
Recoverable on paid losses
|
|
|
|
|||||||||
|
Ceded benefit reserves
|
|
( |
)
|
( |
)
|
|||||||
|
Ceded unearned premiums
|
|
|
|
|||||||||
|
Ceded advanced premiums
|
|
|
|
|||||||||
|
Total reinsurance receivables
|
$
|
|
$
|
|
$
|
|
||||||
|
Reinsurance Concentration
|
2025
|
2024
|
||||||||||
|
General Re
|
|
|
||||||||||
|
General Re percentage
|
|
%
|
|
%
|
|
Year Ended December 31
|
||||||||
|
2025
|
2024
|
|||||||
|
Total tax expense (benefit) on income
|
$
|
|
$
|
( |
)
|
|||
|
Tax expense (benefit) on components of shareholders’ equity:
|
||||||||
|
Unrealized gains and losses on available-for-sale fixed maturity securities, including reclassification adjustments
|
|
( |
)
|
|||||
|
LDTI future policy benefit discount-rate remeasurement, net of the related reinsurance-recoverable effect
|
( |
)
|
|
|||||
|
Total tax expense on components of shareholders’ equity
|
|
|
||||||
|
Total tax expense
|
$
|
|
$
|
|
||||
|
Year Ended December 31
|
||||||||
|
2025
|
2024
|
|||||||
|
Federal income tax provision at the statutory rate
|
$
|
$
|
)
|
|||||
|
Statutory rate
|
|
%
|
|
%
|
||||
|
Dividends-received deduction
|
( |
)
|
( |
)
|
||||
|
Meals and entertainment
|
|
|
||||||
|
Vested stock and club dues
|
|
|
||||||
|
Parking disallowance
|
|
|
||||||
|
Adjustment for prior years’ estimates to actual
|
|
|
||||||
|
Income tax expense (benefit)
|
$
|
|
$
|
( |
)
|
|||
|
Effective tax rate
|
|
%
|
|
%
|
||||
| State income taxes, net of federal income tax effect(1)(2) | ||||||||
|
2025
|
2024
|
|||||||
|
Deferred tax assets:
|
||||||||
|
Deferred acquisition costs
|
$
|
|
$
|
|
||||
|
Net unrealized investment losses
|
|
|
||||||
|
Impaired assets
|
|
|
||||||
|
Bad debts and other
|
|
|
||||||
|
Net operating loss
|
|
|
||||||
|
Other
|
|
|
||||||
|
Total deferred tax assets
|
|
|
||||||
|
Deferred tax liabilities:
|
||||||||
|
Deferred and uncollected premiums
|
$
|
( |
)
|
$
|
( |
)
|
||
|
Insurance reserves
|
( |
)
|
( |
)
|
||||
|
Total deferred tax liabilities
|
( |
)
|
( |
)
|
||||
|
Net deferred tax asset
|
$
|
|
$
|
|
||||
|
Year Ended December 31
|
||||||||
|
2025
|
2024
|
|||||||
|
Federal
|
||||||||
|
Current U.S. income tax expense
|
$
|
$
|
|
|||||
|
Deferred U.S. income tax expense (benefit)
|
( |
)
|
( |
)
|
||||
|
$
|
|
$
|
( |
)
|
||||
| Atlantic American Statutory Trust I | Atlantic American Statutory Trust II | |||||||
| JUNIOR SUBORDINATED DEBENTURES(1)(2) | ||||||||
| Balance December 31, 2025 | $ | | $ | | ||||
| Less: Treasury debt(3) | | ( | ) | |||||
| Net balance December 31, 2025 | $ | | $ | | ||||
| Net balance December 31, 2024 | $ | | $ | | ||||
| Coupon rate | | | ||||||
| Interest payable | | | ||||||
| Maturity date | | | ||||||
| Redeemable by issuer | | | ||||||
| TRUST PREFERRED SECURITIES | ||||||||
| Issuance date | | | ||||||
| Securities issued | | | ||||||
| Liquidation preference per security | $ | | $ | | ||||
| Liquidation value | $ | | $ | | ||||
| Coupon rate | | | ||||||
| Distribution payable | | | ||||||
| Distribution guaranteed by(4) | | |
| (1) | |
| (2) |
| (3) |
| (4) | |
| Year Ended December 31, 2025 | Year Ended December 31, 2024 | |||||||
| Other information on operating leases: | ||||||||
| Cash payments included in the measurement of lease liabilities reported in operating cash flows | $ | | $ | | ||||
| Right-of-use assets included in on the consolidated balance sheet | | | ||||||
| Weighted average discount rate | | % | | % | ||||
| Weighted average remaining lease term in years | | | ||||||
|
Lease Liability
|
||||
|
2026
|
$
|
|
||
|
2027
|
|
|||
|
2028
|
|
|||
|
2029
|
|
|||
|
2030
|
|
|||
|
Thereafter
|
|
|||
|
Total undiscounted lease payments
|
|
|||
|
Less: present value adjustment
|
|
|||
| Operating lease liability included in on the consolidated balance sheet |
$
|
|
||
|
For the Year Ended December 31, 2025
|
| Income | Weighted Average Shares Outstanding (in thousands) | Per Share Amount | |||||||||
| Basic and Diluted Earnings Per Common Share | |||||||||||
| Net income before preferred stock dividends | $ | | | ||||||||
| Less preferred stock dividends | ( | ) | - | ||||||||
| Net income applicable to common shareholders | $ | | | $ | | ||||||
| For the Year Ended December 31, 2024 (Restated) | |||||||||||
| Loss | Weighted Average Shares Outstanding (in thousands) | Per Share Amount | |||||||||
| Basic and Diluted Loss Per Common Share | |||||||||||
| Net loss before preferred stock dividends | $ | ( | ) | | |||||||
| Less preferred stock dividends | ( | ) | - | ||||||||
| Net loss applicable to common shareholders | $ | ( | ) | | $ | ( | ) | ||||
|
2025
|
2024
|
|||||||
|
Bankers Fidelity, net income
|
$
|
|
$
|
|
||||
|
American Southern, net income
|
|
|
||||||
|
Statutory net income
|
$
|
|
$
|
|
||||
|
Bankers Fidelity, capital and surplus
|
$
|
|
$
|
|
||||
|
American Southern, capital and surplus
|
|
|
||||||
|
Statutory capital and surplus
|
$
|
|
$
|
|
||||
| For the Year Ended December 31, 2025 | ||||||||||||||||||||
|
American
Southern
|
Bankers
Fidelity
|
Corporate
& Other
|
Adjustments
& Eliminations
|
Consolidated
|
||||||||||||||||
|
Insurance premiums, net
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||
|
Insurance benefits and losses incurred
|
|
|
|
|
|
|||||||||||||||
|
Future policy benefit remeasurement gain
|
|
( |
)
|
|
|
( |
)
|
|||||||||||||
|
Expenses deferred
|
( |
)
|
( |
)
|
|
|
( |
)
|
||||||||||||
|
Amortization and depreciation expense
|
|
|
|
|
|
|||||||||||||||
|
Other expenses
|
|
|
|
( |
)
|
|
||||||||||||||
|
Total expenses
|
|
|
|
( |
)
|
|
||||||||||||||
|
Underwriting income (loss)
|
|
|
|
|
|
|||||||||||||||
|
Net investment income (loss)
|
|
|
|
( |
)
|
|
||||||||||||||
|
Other income (loss)
|
|
|
|
( |
)
|
|
||||||||||||||
|
Subtotal
|
|
|
( |
)
|
|
|
||||||||||||||
|
Net realized gains (losses)
|
( |
)
|
|
|
|
( |
)
|
|||||||||||||
|
Unrealized gains on equity securities
|
|
|
|
|
|
|||||||||||||||
|
Income (loss) before income taxes
|
$
|
|
$
|
|
$
|
( |
)
|
$
|
|
$
|
|
|||||||||
|
Total revenues
|
$
|
|
$
|
|
$
|
|
$
|
( |
)
|
$
|
|
|||||||||
|
Intangibles
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||
|
Total assets
|
$
|
|
$
|
|
$
|
$
|
( |
)
|
$
|
|||||||||||
|
For the Year Ended December 31, 2024 (Restated)
|
||||||||||||||||||||
|
American
Southern |
Bankers
Fidelity
|
Corporate
& Other
|
Adjustments
& Eliminations
|
Consolidated
|
||||||||||||||||
|
Insurance premiums, net
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||
|
Insurance benefits and losses incurred
|
|
|
|
|
|
|||||||||||||||
|
Future policy benefit remeasurement gain
|
|
( |
)
|
|
|
( |
)
|
|||||||||||||
|
Expenses deferred
|
( |
)
|
( |
)
|
|
|
( |
)
|
||||||||||||
|
Amortization and depreciation expense
|
|
|
|
|
|
|||||||||||||||
|
Other expenses
|
|
|
|
( |
)
|
|
||||||||||||||
|
Total expenses
|
|
|
|
( |
)
|
|
||||||||||||||
|
Underwriting income (loss)
|
( |
)
|
|
|
|
( |
)
|
|||||||||||||
|
Net investment income (loss)
|
|
|
|
( |
)
|
|
||||||||||||||
|
Other income (loss)
|
|
|
|
( |
)
|
|
||||||||||||||
|
Subtotal
|
|
|
( |
)
|
|
( |
)
|
|||||||||||||
|
Net realized gains
|
|
|
|
|
|
|||||||||||||||
|
Unrealized losses on equity securities
|
( |
)
|
( |
)
|
( |
)
|
|
( |
)
|
|||||||||||
|
Income (loss) before income taxes
|
$
|
|
$
|
|
$
|
( |
)
|
$
|
|
$
|
( |
)
|
||||||||
|
Total revenues
|
$
|
|
$
|
|
$
|
|
$
|
( |
)
|
$
|
|
|||||||||
|
Intangibles
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||
|
Total assets
|
$
|
|
$
|
|
$
|
|
$
|
( |
)
|
$
|
|
|||||||||
| Item 9. |
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
|
| Item 9A. |
Controls and Procedures
|
| • |
Implementing controls to validate inbound enrollment files against approved formats and business rules;
|
| • |
Establishing procedures to communicate exceptions to submitting partners and require correction before information is processed by the policy-administration system;
|
| • |
Implementing documented manual validation and exception-review controls while the automated solution is being developed and tested;
|
| • |
Establishing recurring policy-level reconciliations among enrollment data, billing records, cash receipts, policy status, due-premium balances, suspense balances and the general ledger; and
|
| • |
Establishing formal aging, investigation, disposition and escalation requirements for due-premium and suspense balances;
|
| • |
Adding personnel or engaging qualified third-party resources with specialized technical accounting, actuarial and internal control expertise to support the ongoing application of LDTI;
|
| • |
Enhancing controls over actuarial valuation-related data inputs, assumptions, model configurations, actuarial calculations, as well as actuarial based journal entries, account reconciliations and financial statement disclosures;
and
|
| • |
Establishing formal actuarial-to-accounting handoff and review controls designed to ensure that complete, accurate and timely information is provided and reviewed before completion of the financial statement close process.
|
| • | Implementing controls to reconcile final tax reserves and premium to the corresponding tax attributes used in the income tax provision; and |
| • | Enhancing the independent review of current and deferred income tax expense, deferred tax assets and liabilities, and related equity effects using defined review
criteria and thresholds, as well as model changes. |
| Item 9B. |
Other Information
|
| Item 9C. |
Disclosure Regarding Foreign Jurisdictions that Prevent Inspections
|
| Item 10. |
Directors, Executive Officers and Corporate Governance
|
|
Name
|
Age
|
Position with the Company
|
||
|
Hilton H. Howell, Jr.
|
64
|
Chairman of the Board, President and Chief Executive Officer
|
||
|
Robin R. Howell
|
62
|
Director
|
||
|
Mark E. Preisinger
|
66
|
Director
|
||
|
Joseph M. Scheerer
|
52
|
Director
|
||
|
Scott G. Thompson
|
81
|
Director
|
||
|
D. Keehln Wheeler
|
65
|
Director
|
|
Name and Principal Position
|
Year | Salary ($) |
Bonus ($)(1) |
Stock Awards ($) |
All Other Compensation ($) |
Total ($)(2) | ||||||||||||||||
|
Hilton H. Howell, Jr.
|
2025 | 600,000 | 850,000 | - | 165,566 | (3) | 1,615,566 | |||||||||||||||
|
Chairman of the Board, President and CEO
|
2024 | 594,792 | 800,000 | - | 165,116 | 1,559,908 | ||||||||||||||||
|
J. Ross Franklin
(4)
|
2025 | 427,220 | 375,000 | - | 62,670 | (5) | 864,890 | |||||||||||||||
|
Former Vice President, CFO and Secretary
|
2024 | 419,399 | 350,000 | - | 63,366 | 832,765 |
|
Stock Awards
|
||||||||||||||||
|
Name
|
Number of
Shares
or Units of
Stock
That Have
Not
Vested (#)
|
Market
Value of
Shares or
Units of
Stock That
Have
Not Vested
($)
|
Equity
Incentive
Plan
Awards:
Number of
Unearned
Shares,
Units or
Other
Rights
That Have
Not Vested (#)
|
Equity
Incentive
Plan
Awards:
Market or
Payout
Value of
Unearned
Shares,
Units
or Other
Rights that
Have Not
Vested ($)
|
||||||||||||
|
Hilton H. Howell, Jr.
|
-
|
-
|
-
|
-
|
||||||||||||
|
J. Ross Franklin
|
-
|
-
|
-
|
-
|
||||||||||||
|
2025 Director Compensation
|
||||||||||||||||
|
Name
|
Fees
Earned
or Paid in
Cash
($)
|
Stock
Awards
($)
|
All Other
Compensations
($)
|
Total
($)
|
||||||||||||
|
Robin R. Howell
|
80,000
|
-
|
-
|
80,000
|
(1)
|
|||||||||||
|
Mark E. Preisinger
|
90,000
|
-
|
-
|
90,000
|
||||||||||||
|
Joseph M. Scheerer
|
90,000
|
-
|
-
|
90,000
|
||||||||||||
|
Scott G. Thompson
|
80,000
|
-
|
-
|
(2)
|
80,000
|
|||||||||||
|
D. Keehln Wheeler
|
90,000
|
-
|
-
|
90,000
|
||||||||||||
| Item 12. |
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
|
|
Common Stock
|
Series D Preferred Stock(1)
|
|||||||||||||||
|
Name of Stockholder
|
Number of
Shares
|
Percent
of Class
|
Number of
Shares
|
Percent
of Class
|
||||||||||||
|
Estate of Harriett J. Robinson
|
15,217,583
|
(2)
|
74.61
|
%
|
55,000
|
100
|
%
|
|||||||||
|
Hilton H. Howell, Jr.
|
869,393
|
(3)
|
4.26
|
%
|
-
|
-
|
||||||||||
|
Robin R. Howell
|
3,988,356
|
(4)
|
19.55
|
%
|
-
|
-
|
||||||||||
|
Mark E. Preisinger
|
20,000
|
*
|
-
|
-
|
||||||||||||
|
Joseph M. Scheerer
|
30,000
|
*
|
-
|
-
|
||||||||||||
|
Scott G. Thompson
|
145,959
|
*
|
-
|
-
|
||||||||||||
|
D. Keehln Wheeler
|
30,000
|
*
|
-
|
-
|
||||||||||||
|
J. Ross Franklin
|
36,942
|
*
|
-
|
-
|
||||||||||||
|
All directors and executive officers as a group (6 persons)
|
5,049,633
|
24.76
|
%
|
-
|
|
-
|
|
|||||||||
|
Plan Category
|
Number of
Securities to Be
Issued Upon
Exercise of
Outstanding
Options,
Warrants
and Rights
|
Weighted-Average
Exercise Price
of Outstanding
Options,
Warrants
and Rights
|
Number of Securities
Remaining Available
for Future Issuance
Under Equity
Compensation Plans
(Excluding Securities
Reflected in the
First Column)
|
|||||||||
|
Equity compensation plans approved by security holders
|
-
|
$
|
-
|
2,960,000
|
||||||||
|
Equity compensation plans not approved by security holders(1)
|
-
|
-
|
-
|
|||||||||
|
Total
|
-
|
$
|
-
|
2,960,000
|
||||||||
| Item 13. |
Certain Relationships and Related Transactions, and Director Independence
|
| Item 14. |
Principal Accountant Fees and Services
|
| Item 15. |
Exhibits and Financial Statement Schedules
|
| 1. |
Financial Statements:
|
| 2. |
Financial Statement Schedules:
|
| 3. |
Exhibits*:
|
|
Restated Articles of Incorporation of the registrant, as amended [incorporated by reference to Exhibit 3.1 to the registrant’s Form 10-K for the year ended December 31, 2008].
|
|
|
Restated Bylaws of the registrant, as amended [incorporated by reference to Exhibit 3.1 to the registrant’s Form 8-K filed on March 4, 2016].
|
|
|
Description of the registrant’s common stock registered pursuant to section 12 of the Securities Exchange Act of 1934 [incorporated by reference to Exhibit 4.1 to the registrant’s Form 10-K filed on March 24,
2020].
|
|
|
10.01
|
Management Agreement, dated July 1, 1993, between the registrant and Atlantic American Life Insurance Company and Bankers Fidelity Life Insurance Company [incorporated by reference to Exhibit 10.41 to the
registrant’s Form 10-Q for the quarter ended September 30, 1993].
|
|
Tax Allocation Agreement, dated as of January 4, 2016, between the registrant and the registrant’s subsidiaries [incorporated by reference to Exhibit 10.02 to the registrant’s Form 10-K for the year ended
December 31, 2017].
|
|
|
Atlantic American Corporation 2012 Nonqualified Stock Purchase Plan [incorporated by reference to Exhibit 99.1 to the registrant’s Form S-8 (File No. 333-183207) filed on August 10, 2012].
|
|
|
Atlantic American Corporation 2012 Equity Incentive Plan [incorporated by reference to Exhibit 10.1 to the registrant’s Form 10-Q for the quarter ended March 31, 2013].
|
|
|
Lease Agreement, dated as of November 1, 2007, between Georgia Casualty & Surety Company, Bankers Fidelity Life Insurance Company, Atlantic American Corporation and Delta Life Insurance Company
[incorporated by reference to Exhibit 10.10 to the registrant’s Form 10-K for the year ended December 31, 2007].
|
|
|
First Amendment to Lease Agreement, dated as of March 31, 2008, between Georgia Casualty & Surety Company, Bankers Fidelity Life Insurance Company, Atlantic American Corporation and Delta Life Insurance
Company [incorporated by reference to Exhibit 10.2 to the registrant’s Form 10-Q for the quarter ended March 31, 2008].
|
|
|
Assignment and Assumption of Leases and Contracts, dated as of December 21, 2022, by and between Delta Life Insurance Company and 4370 Peachtree LLC [incorporated by reference to Exhibit 10.07 to the
registrant’s Form 10-K filed on June 30, 2023].
|
|
|
Revolving Credit Agreement, dated as of May 12, 2021, as amended by that certain First Amendment to Revolving Credit Agreement, dated as of March 22, 2024, by and between Atlantic American Corporation and
Truist Bank [incorporated by reference to Exhibit 10.1 to the registrant’s Form 8-K filed with the SEC on May 13, 2021].
|
|
|
Atlantic American Corporation 2022 Equity and Incentive Compensation Plan [incorporated by reference to Exhibit 10.1 to the registrant’s Form 8-K filed on May 31, 2022].
|
|
|
|
Second Amendment to Lease Agreement, dated as of December 26, 2024, by and among 4370 Peachtree LLC, Atlantic American Corporation and Bankers Fidelity Life Insurance Company
[incorporated by reference to Exhibit 10.1 to the registrant’s Form 8-K filed with the SEC on December 30, 2024].
|
|
Second Amendment to Revolving
Credit Agreement, dated as of May 27, 2026, by and between Atlantic American
Corporation and Truist Bank
[incorporated by reference to Exhibit 10.1 to the registrant’s Form 8-K filed
on June 2, 2026].
|
|
| Third Amendment to Revolving Credit Agreement, dated as of July 31, 2026, by and between Atlantic American Corporation and Truist Bank [incorporated by reference to Exhibit 10.1 to the registrant's Form 8-K filed on August 5, 2026]. | |
| Code of Business Conduct and Ethics [incorporated by reference to Exhibit 14.1 to the registrant’s Form 10-K for the year ended December 31, 2003]. | |
|
Atlantic American Corporation Insider Trading Policy [incorporated by reference to Exhibit 19.1 to the registrant’s Form 10-K for the year ended December 31, 2024].
|
|
| Subsidiaries of the registrant. | |
| Consent of Forvis Mazars, LLP, Independent Registered Public Accounting Firm. | |
| Certification of the Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
|
Certification of the Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
Certifications pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
| 97.1 |
Atlantic American Corporation Compensation Clawback Policy [incorporated by reference to the Exhibit 97.1 to the registrant’s Form 10-K for the year ended December 31, 2024]. |
|
101.INS
|
Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document). |
|
101.SCH
|
Inline XBRL Taxonomy Extension Schema.
|
|
101.CAL
|
Inline XBRL Taxonomy Extension Calculation Linkbase.
|
|
101.DEF
|
Inline XBRL Taxonomy Extension Definition Linkbase.
|
|
101.LAB
|
Inline XBRL Taxonomy Extension Label Linkbase.
|
|
101.PRE
|
Inline XBRL Taxonomy Extension Presentation Linkbase.
|
|
104
|
Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).
|
| Item 16. |
Form 10-K Summary
|
|
ATLANTIC AMERICAN CORPORATION
|
||
|
(Registrant)
|
||
|
By:
|
/s/ Nickeesha Bates
|
|
|
Nickeesha Bates
|
||
|
Vice President, Corporate Controller, Corporate
Accounting/Finance
|
||
|
Date: October 16, 2026
|
|
Signature
|
Title
|
Date
|
||
|
/s/ Hilton H. Howell, Jr.
|
President, Chief Executive Officer and Chairman of the Board
(Principal Executive Officer)
|
October 16, 2026
|
||
|
HILTON H. HOWELL, JR.
|
||||
|
/s/ Nickeesha Bates
|
Vice President, Corporate Controller, Corporate Accounting/Finance
(Acting Principal Financial and Accounting Officer)
|
October 16, 2026
|
||
|
NICKEESHA BATES
|
||||
|
/s/ Robin R. Howell
|
Director
|
October 16, 2026
|
||
|
ROBIN R. HOWELL
|
||||
|
/s/ Mark E. Preisinger
|
Director
|
October 16, 2026
|
||
|
MARK E. PREISINGER
|
||||
|
/s/ Joseph M. Scheerer
|
Director
|
October 16, 2026
|
||
|
JOSEPH M. SCHEERER
|
||||
|
/s/ Scott G. Thompson
|
Director
|
October 16, 2026
|
||
|
SCOTT G. THOMPSON
|
||||
|
/s/ D. Keehln Wheeler
|
Director
|
October 16, 2026
|
||
|
D. KEEHLN WHEELER
|
|
December 31,
|
||||||||
|
2025
|
2024
|
|||||||
|
(Restated)
|
||||||||
|
ASSETS
|
(In thousands)
|
|||||||
|
Cash and cash equivalents
|
$
|
|
$
|
|
||||
|
Investments
|
|
|
||||||
|
Investment in subsidiaries
|
|
|
||||||
|
Investments in unconsolidated trusts
|
|
|
||||||
|
Deferred tax asset, net
|
|
|
||||||
|
Income taxes receivable from subsidiaries
|
|
|
||||||
|
Other assets
|
|
|
||||||
|
Total assets
|
$
|
|
$
|
|
||||
|
|
||||||||
|
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
||||||||
|
Other payables
|
$
|
|
$
|
|
||||
|
Revolving credit facility
|
|
|
||||||
|
Junior subordinated debentures obligations, net
|
|
|
||||||
|
Total liabilities
|
|
|
||||||
|
|
||||||||
|
Shareholders’ equity
|
|
|
||||||
|
Total liabilities and shareholders’ equity
|
$
|
|
$
|
|
||||
|
Year Ended December 31,
|
||||||||
|
2025
|
2024
|
|||||||
|
(Restated)
|
||||||||
|
(In thousands)
|
||||||||
|
Revenue
|
||||||||
|
Fee income from subsidiaries
|
$
|
|
$
|
|
||||
|
Distributed earnings from subsidiaries
|
|
|
||||||
|
Unrealized losses on equity securities, net
|
|
( |
)
|
|||||
|
Other
|
( |
)
|
( |
)
|
||||
|
Total revenue
|
|
|
||||||
|
General and administrative expenses
|
|
|
||||||
|
Interest expense
|
|
|
||||||
| ( |
)
|
( |
)
|
|||||
|
Income tax benefit(1)
|
|
|
||||||
| |
||||||||
|
Equity in undistributed earnings of subsidiaries, net
|
( |
)
|
||||||
|
Net income (loss)
|
$
|
|
$
|
( |
)
|
|||
|
Year Ended December 31,
|
||||||||
|
2025
|
2024
|
|||||||
| (Restated) | ||||||||
| (In thousands) | ||||||||
|
Cash flows from operating activities:
|
||||||||
|
Net income (loss)
|
$
|
|
$
|
( |
)
|
|||
|
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
|
||||||||
|
Unrealized (gains) losses on equity securities, net
|
( |
)
|
|
|||||
|
Depreciation and amortization
|
|
|
||||||
|
Compensation expense related to share awards
|
|
|
||||||
|
(Deficit) equity in undistributed earnings of consolidated subsidiaries
|
( |
)
|
|
|||||
|
(Increase) decrease in intercompany taxes
|
( |
)
|
|
|||||
|
Deferred income tax (benefit) expense
|
( |
)
|
( |
)
|
||||
|
(Increase) decrease in accounts payable and accrued expenses
|
( |
)
|
|
|||||
|
Other, net
|
( |
)
|
( |
) | ||||
|
Net cash (used in) provided by operating activities
|
( |
)
|
|
|||||
|
Cash flows from investing activities:
|
||||||||
|
Additions to property and equipment
|
( |
)
|
( |
)
|
||||
|
Net cash used in investing activities
|
( |
)
|
( |
)
|
||||
|
Cash flows from financing activities:
|
||||||||
|
Payment of dividends on Series D preferred stock
|
( |
)
|
( |
)
|
||||
|
Payment of dividends on common stock
|
( |
)
|
( |
)
|
||||
|
Proceeds from shares issued under stock plans
|
|
|
||||||
|
Proceeds from revolving credit facility, net
|
|
|
||||||
|
Treasury stock acquired — net employee share-based compensation
|
( |
)
|
( |
)
|
||||
|
Net cash provided by financing activities
|
|
|
||||||
|
Net increase in cash
|
( |
)
|
|
|||||
|
Cash and cash equivalents at beginning of year
|
|
|
||||||
|
Cash and cash equivalents at end of year
|
$
|
|
$
|
|
||||
|
Supplemental disclosure:
|
||||||||
|
Cash paid for interest
|
$
|
|
$
|
|
||||
|
Cash paid for federal income taxes
|
$
|
|
$
|
|
||||
|
Cash paid for state income taxes
|
$
|
|
$
|
|
||||
|
Intercompany tax settlement from subsidiaries
|
$
|
|
$
|
|
||||
| Segment |
Deferred Acquisition Costs |
Future Policy Benefits, Losses, Claims and Loss Reserves |
Unearned Premiums |
Other Policy Claims and Benefits Payable |
||||||||||||
| (In thousands) |
||||||||||||||||
| December 31, 2025: |
||||||||||||||||
|
Bankers Fidelity
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
American Southern
|
|
|
|
|
||||||||||||
|
|
$
|
|
$
|
|
(1)
|
$
|
|
$
|
|
|||||||
|
|
||||||||||||||||
|
December 31, 2024 (Restated):
|
||||||||||||||||
|
Bankers Fidelity
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
American Southern
|
|
|
|
|
||||||||||||
|
|
$
|
|
$
|
|
(2)
|
$
|
|
$
|
|
|||||||
| Segment |
Premium Revenue |
Net Investment Income |
Claims, Losses and Settlement Expenses |
Amortization of Deferred Acquisition Costs |
Other Operating Expenses |
Casualty Premiums Written |
||||||||||||||||||
| (In thousands) |
||||||||||||||||||||||||
| December 31, 2025: |
||||||||||||||||||||||||
|
Bankers Fidelity
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||
|
American Southern
|
|
|
|
|
|
|
||||||||||||||||||
|
Corporate & other
|
|
|
|
|
|
|
||||||||||||||||||
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
|||||||||||||
|
December 31, 2024 (Restated):
|
||||||||||||||||||||||||
|
Bankers Fidelity
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||
|
American Southern
|
|
|
|
|
|
|
||||||||||||||||||
|
Corporate & other
|
|
|
|
|
|
|
||||||||||||||||||
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
|||||||||||||
|
Direct
Amount
|
Ceded To
Other
Companies
|
Assumed
From Other
Companies
|
Net
Amounts
|
Percentage
of Amount
Assumed
To Net
|
||||||||||||||||
|
(In thousands)
|
||||||||||||||||||||
|
Year Ended December 31, 2025:
|
||||||||||||||||||||
|
Life insurance in force
|
$
|
|
$
|
( |
)
|
$
|
|
$
|
|
|||||||||||
|
Premiums
|
||||||||||||||||||||
|
Bankers Fidelity
|
$
|
|
$
|
( |
)
|
$
|
|
$
|
|
|
%
|
|||||||||
|
American Southern
|
|
( |
)
|
|
|
|
%
|
|||||||||||||
|
Total premiums
|
$
|
|
$
|
( |
)
|
$
|
|
$
|
|
|
%
|
|||||||||
|
Year Ended December 31, 2024 (Restated):
|
||||||||||||||||||||
|
Life insurance in force
|
$
|
|
$
|
( |
)
|
$
|
|
$
|
|
|||||||||||
|
Premiums
|
||||||||||||||||||||
|
Bankers Fidelity
|
$
|
|
$
|
( |
)
|
$
|
|
$
|
|
|
%
|
|||||||||
|
American Southern
|
|
( |
)
|
|
|
|
%
|
|||||||||||||
|
Total premiums
|
$
|
|
$
|
( |
)
|
$
|
|
$
|
|
|
%
|
|||||||||
|
Claims and Claim
Adjustment
Expenses Incurred
Related To
|
||||||||||||||||||||||||||||||||||||||||
|
Year Ended
|
Deferred
Policy
Acquisition
Costs
|
Reserves
|
Unearned
Premiums
|
Earned
Premiums
|
Net
Investment
Income
|
Current
Year
|
Prior
Years
|
Amortization
of Deferred
Acquisition
Costs
|
Paid Claims
and Claim
Adjustment
Expenses
|
Net
Premiums
Written
|
||||||||||||||||||||||||||||||
|
(In thousands)
|
||||||||||||||||||||||||||||||||||||||||
|
December 31, 2025
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||||||
|
December 31, 2024
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||||||||||